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The over five million people in the U.S. living with dementia are at an elevated risk of 
other negative health outcomes due to a diminished ability to care for themselves, contributing 
significantly to healthcare costs. There is evidence that traumatic life events (TLE) influence later-
life cognitive function and decline through chronic activation of the HPA axis. One likely 
mechanism through which TLEs impact cognition is immune system alterations.  
Using data on 7,785 participants aged 65+ from the Health and Retirement Study (HRS) 
and 1,337 participants aged 60+ from the Sacramento Area Latino Study of Aging (SALSA), we 
investigated these relationships. In HRS, we estimated the association between TLEs and cognitive 
trajectories and incident dementia from 2006 to 2016. In SALSA, we estimated the associations 
between baseline immune biomarkers and cognitive outcomes over 10 years. Linear mixed effects 
models were used to examine these associations and potential interactions or effect measure 
modification. Stratified cumulative incidence functions were calculated to investigate risk of 
dementia.  
We found that TLEs were associated with a higher level of cognitive function and faster 
rate of decline but not with dementia incidence. The associations were strongest among those who 
experienced TLEs in late life and those with the lowest educational attainment. However, the type 
of TLE determined not only the strength but also the direction of the association. We also found 
that IL-6, TNF-alpha, and CMV IgG levels were associated with poorer cognitive function in 
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SALSA, and the identified relationships were modified by educational attainment. Additionally, 
IL-6, TNF-alpha, and HSV-1 interacted with cortisol to alter the relationships with cognitive level 
and age. We did not find any statistically significant associations between exposures and dementia 
incidence.  
These findings suggest that TLEs may impact cognitive function and rate of cognitive 
decline in late life, timing of these events within the lifecourse is important, and these relationships 
are modified by educational attainment. Furthermore, elevated immune biomarkers may be 
indicative of lower cognitive function or accelerating decline in older populations. These 
relationships were modified by educational attainment, and cortisol may interact with immune 
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CHAPTER 1: REVIEW OF THE LITERATURE 
1.1 Epidemiology of cognitive decline and dementia in the United States 
Cognitive decline is a normal phenomenon among the elderly. As humans age, our 
reasoning, memory, and processing speed begin to decline in young adulthood, and our brains 
physically change with age, including decreasing grey matter volume, formation of β-amyloid 
plaques, and neuronal cell death.2 Functional deficits in reasoning, memory, processing speed, 
etc. characterize cognitive decline clinically, while the physiologic changes in the brain define it 
biologically. Dementia is an umbrella term describing any chronic disorder of mental processes 
caused by brain disease and marked by clinical presentation of memory malfunction, personality 
change, or impaired ability to reason. There are several types of dementia, the most prevalent of 
which, in the U.S., is Alzheimer’s Disease (AD), representing approximately 70% of dementia.3 
However, there is significant heterogeneity in the rate at which individuals’ brain function 
declines and the age at which this decline crosses the threshold into clinical cognitive impairment 
and dementia. Social disparities in dementias in particular exist, with women (for AD) and men 
(for VaD), non-Whites, and those less educated shouldering a disproportionately high burden of 
the disease.4-6 Hypotheses for the origin of these disparities include lifestyle, genetic factors, and 
baseline cognitive ability, which have been shown to contribute to decline,7 but much of the 
variation remains unexplained. AD, first defined in 1906 by Dr. Alois Alzheimer, is 
characterized by memory loss and mental confusion, and based on postmortem identification of 
amyloid plaques and neurofibrillary tangles in the brain.8 Other dementias are also the result of 
specific brain pathologies. For example, Lewy Body dementia is characterized by the presence of 
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Lewy Bodies in the brain.9 However, VaD, the second most common form of dementia,3 is often 
the result of an acute event such as stroke.9 Research into the brain physiology changes that 
result in dementia is still ongoing, but there is also a rich research literature investigating 
environmental risk factors and demographic distribution of cognitive decline and dementia 
burden around the world and in the U.S. 
Using data from the Health and Retirement Study (HRS), researchers estimate that the 
prevalence of dementia, of all types, in the U.S. among those aged 71 years and above is 13.9%, 
or 3.4 million people, as of 2002.3 The prevalence increases dramatically as you move up in age 
categories, unsurprisingly, with 37.4% of those over 89 years. Of those 3.4 million dementia 
cases, an estimated 2.4 million (or 70.5%) were AD. As of 2016, VaD and AD together affect an 
estimated 5.2 million people over the age of 65.1 This burden will only continue to grow through 
the next several decades, with an estimated 14 million cases of AD projected in the U.S. by 
2050.1 Starting at 65 years old, the age after which onset is typical and no longer considered 
“early onset”, the risk of developing AD doubles every 5 years.10 Women bear a much larger 
burden of AD cases compared to men in the U.S., with approximately 71.5% of AD cases in the 
Aging, Demographics, and Memory Study (ADAMS) among females, though only 60.7% of the 
study population was female. Additionally, those in lower educational attainment categories bear 
a larger burden than those with greater than a high school diploma, with around 33% of AD and 
VaD cases being among those who received <9 years of education despite the only 17.4% of the 
study population falling into that category.3  
However, there are also several well-established risk factors for dementia besides age, 
sex, race/ethnicity, and educational attainment, with varying levels of strength of evidence. 
Those risk factors most strongly associated with the risk of AD include diabetes mellitus, 
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hypercholesteremia, obesity, current smoking, lower social engagement, head injury in males, 
and APOE-e4.11 On the other hand, there are also several behaviors, biological markers, and 
social factors which are considered protective against dementia. These include the use of statins, 
light to moderate alcohol use, a healthy diet, higher educational attainment, physical activity, 
cognitively stimulating activities, and APOE-e2.11  
When considering simply cognitive level and cognitive decline in old age, the risk factors 
are very similar to those of dementia as it is the process of cognitive decline that leads to 
dementia. One interesting difference is with the level of educational attainment. While it has 
been established that those with higher educational attainment show a decreased incidence of 
MCI and dementia over a given time period, the literature has also found that those with higher 
educational attainment experience a faster decline once decline begins.12 This may be due to the 
ability to mask early levels of decline and/or compensate for cognitive deficiencies, resulting in a 
later manifestation of clinical symptoms of dementia, a capacity referred to in the literature as 
“cognitive reserve”.13 This concept will be discussed at length later in this chapter. 
Despite these numerous risk factors, much of the variance in cognitive decline and 
dementia incidence across the population remains unexplained. We propose that psychosocial 
stressors explain a significant proportion of this heterogeneity, and that immunosenescence 
partially mediates the pathway through which these lifecourse factors affect cognition and risk of 
dementia. Therefore, we aim to quantify the relationship between these stressors across the 
lifecourse and both cognitive decline and onset of dementia. Existing evidence to this effect and 
particular gaps in the research are described in detail below. It is uncertain to what extent these 
stressors, which occur across the lifecourse, contribute to this heterogeneity. Given the large and 
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growing burden of dementia in the U.S., it is important to clearly understand these associations 
to optimize prevention strategies.  
1.2 Psychosocial stress and cognitive decline & dementia 
Stressors are typically defined as any stimulus that disrupts homeostasis. Psychosocial 
stressors, on the other hand, are any external stimulus from the social environment that disrupts 
the psychological well-being of an individual. Psychosocial stressors can be thought of similarly 
to the more generic ‘biological’ stressors in that they have downstream effects on physiology that 
result in long term health consequences. They are always ‘external stimuli’ in that biological sex 
itself is not a psychosocial stressor, but rather the experience of sexism in a society structured to 
value men more than women can be a psychosocial stressor. 
Examples of psychosocial stressors include divorce, unemployment, traumatic events 
such as the death of a child, low job control and high job demands, social isolation, and 
discrimination, among many others. As social epidemiologists we sometimes think about these in 
broad strokes, like "social disadvantage" such as poverty, or “stressful life events”, of which 
divorce and unemployment are examples. Stressors can come from a wide range of sources: 
stressors from interpersonal relationships and interactions are common, but we can also see them 
from institutions (as with employment status and work stress) or communities, and even at the 
governmental level with policies that create or aggravate existing stressors. Furthermore, these 
types of experiences can be stressful on both an acute and a chronic time frame, and thus can 
induce both acute and chronic physiologic responses. For the purposes of this research, we are 
interested how more chronic experiences of these stressors affect cognitive ability as well as 
cognitive decline in later life and incidence of dementia.  
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In this dissertation, we focus on one specific domain of psychosocial stress: traumatic life 
events, discussed below along with several other psychosocial stressors. Financial strain, work 
stress, and social support and loneliness are also major components of psychosocial stress and 
are important factors to consider, but are not within the scope of the exposures for this project.  
1.2.a Lifetime trauma 
As with discrimination and, more broadly, stressful life events, the literature on the 
association between lifetime trauma and cognition, cognitive change, and dementia has yet to 
come to a clear, scientific consensus on whether there is an association or causal relationship, 
and if there is, what direction it is in. However, there is evidence that trauma, and potentially 
resulting psychological conditions such as PTSD, occurring specifically during childhood, 
influence later-life cognitive function, cognitive decline, and incidence of dementia.  
Much of the evidence comes from cross-sectional studies in specialized populations. For 
example, a study in older Aboriginal Australians found that a 1-SD increase in the childhood 
trauma questionnaire (CTQ) score was associated with a 66% increase in the likelihood of being 
diagnosed with dementia.14 A small study of 47 healthy adults in Witchita, KS, found that 
emotional abuse specifically was associated with impaired spatial working memory performance 
while physical neglect was associated with impaired spatial working memory and pattern 
recognition memory.15 Another study found that in former Swiss child laborers, PTSD is 
associated with cognitive deficits whether or not the participant reported childhood trauma.16 
However, among Holocaust survivors, those who had spent time in a Nazi concentration camp 
did not have higher odds of having dementia compared to survivors who were never in a 
concentration camp.17 However, as these are specific populations who all have experienced 
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greater than average stress in their lives, it is possible that the studies do not have adequate 
unexposed groups for meaningful comparisons. 
More representative analyses have found similarly mixed results. Syal et al. found that 
childhood trauma score was significantly associated with poorer spatial and pattern learning in 
women but better learning in men, and these effects were not tempered by later adult adverse 
experiences.18 In a Taiwanese study, PTSD predicted incident dementia over up to 10 years of 
follow-up, and there was a dose-dependent relationship between the severity of PTSD symptoms 
and risk of dementia.19 However, in the Irish Longitudinal Study on Ageing, Feeney et al. found 
that history of childhood sexual abuse was actually associated with better global cognition, 
memory, executive function, and processing speed among adults 50 and older.20 Finally, over 8 
years of follow-up in the Nurses Health Study II, researchers found that elevated PTSD 
symptoms were associated with worse psychomotor speed and working memory scores.21 
Perhaps this indicates that among those for whom stressful events were severe enough to cause a 
clinical disorder, there is a higher risk of dementia compared to those who were similarly 
exposed but did not get a disorder. 
A few studies have also investigated the association between trauma and physical 
measures of brain size, such as hippocampal volume and prefrontal cortex (PFC) thickness, 
precursor indications of declining cognitive function. Karstens et al. found that trauma 
experienced was associated with greater PFC thickness, independent of depression, but was not 
associated with hippocampal volume.22 Another study found that childhood trauma was 
associated with reduced hippocampal volume only in males, not in females,23 while a third study 
specifically looked at women diagnosed with PTSD, dissociative amnesia, or dissociative 
identity disorder from childhood abuse and found that PTSD was associated with reduced 
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amygdala and hippocampal volume as well as impaired cognition, compared to healthy 
controls.24 
As demonstrated above, research has focused on childhood as a particularly sensitive 
period, though no study has yet to do a full population-representative longitudinal study on the 
associations between childhood traumatic experiences and cognitive decline and dementia. 
Furthermore, no study has yet to look at whether there are other sensitive periods across the 
lifecourse, apart from childhood, during which exposure disproportionately affects the outcome 
of interest, and few studies have investigated whether experiences accumulated across the 
lifecourse are a more appropriate measure of traumas to understand the long-term effects on 
cognition. 
1.2.b Other stressful life events 
Stressful life events (SLEs) are discrete events that disrupt regular life activities and 
cause meaningful changes or require substantial adjustment in life. These include events such as 
death of a loved one, divorce, imprisonment, losing a job, and being the victim of a crime. The 
use of this language in the literature is inconsistent, and the stressors described in later sections, 
major experiences of discrimination and traumatic events, may also be considered SLEs in some 
research. Like other stressors, experiencing a number of SLEs can have long-term health 
consequences. A higher number of SLEs has shown to be positively associated with metabolic 
syndrome,25 major depression,26 substance abuse,27 eating disorders,28,29 and potentially cancer.30 
There have been many studies investigating the relationship between SLEs and cognition, 
though most are cross-sectional or cover a very short follow-up period. Furthermore, there are 
very few studies of SLEs and the incidence of dementia. Dickinson et al. found that a decline in 
the number of total SLEs was associated with improvement in global cognition as measured by 
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the CERAD TS.31 Interestingly, a recent article found that very low levels of lifetime stress were 
negatively associated with stimulus-response memory not episodic memory.32 One study found 
that among HIV-positive men, SLEs were statistically significantly associated with cognitive 
impairment.33 A study of those 65 years and older in the Central African Republic and 
Democratic Republic of the Congo found that the total number of SLEs a person experienced 
was associated with Mild Cognitive Impairment (MCI), but the OR was very low at 1.1, and 
barely statistically significant. While the association was slightly stronger when investigating the 
number of SLE’s occurring specifically before the age of 16 (OR 1.6, 95% CI 1.2, 2.2), no 
association was seen with dementia.34 Similar null findings occurred with regard to stressful or 
negative life events and dementia in a study by Sundstrom et al.,35 with cognitive domain 
performance by Ouanes et al.,36 and with MCI by Pilleron et al.34 
In a U.S.-based study of Latino farmworkers, Nguyen et al. found that higher stress 
experienced at study baseline was associated with greater cognitive decline over a three month 
period, though changes in stress over that time were not associated with cognitive change.37 
Another study looking at “recent life stress”, in the past two weeks, found that greater levels of 
this were associated with worse performance on working memory and long-term memory tests, 
as well as on self-reported memory.38 Grimby and Berg found, over 6 years, that cognitive 
decline was not associated with SLEs except in the case of bereavement, suggesting that more 
traumatic events may be more impactful. However, this study may be affected by cohort issues, 
as all participants were age 70 at baseline.39 Finally, Tschanz et al. found that SLE effects on 
cognition over up to 7 years, vary by educational attainment and type of SLE, but their results 
were inconsistent.40  
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Interestingly, several studies found that APOE-4, an allele that indicates a high risk for 
AD, interacts with certain risk factors for accelerated cognitive decline or dementia. Two studies 
investigated this potential interaction between the APOE-4 allele and SLEs. One of these found 
that there was significant interaction between APOE status and SLEs affecting cognitive 
function.41 Furthermore, there were interactions between SLEs and race, with SLEs predicting 
cognitive decline among Caucasians but not African Americans.41 Interestingly, this same article 
found no main effect of SLEs on cognitive function.41 However, the second article, by Chaudry 
et al., which assessed risk of dementia as the outcome, did not find a significant interaction 
between APOE-4 allele and SLEs on risk of dementia.42 In these studies we see the lack of a 
clear pattern in the research conducted thus far. 
To our knowledge, there has been only one additional study assessing the relationship 
between SLEs and the incidence of AD or dementia more generally. Sundstrom et al. found no 
relationship between negative life events and incidence of dementia over up to 22 years of 
follow-up (HR = 0.96, 95% CI = 0.91–1.01), as mentioned above.35 As this is the only study 
investigating this measure longitudinally, more research is required to fully understand the 
hypothesized relationship. Not only will this project add to the literature by assessing the 
relationship between events and both cognitive decline and dementia over a longer period of 
follow-up, but also our research will be able to discern between SLEs taking place during 
childhood (before the age of 18) and different periods in adulthood, allowing us to investigate 
whether any life period is a particularly sensitive period for this relationship. Furthermore, 
comparison of individual life periods is difficult due to the inconsistency of the definition of 
SLEs. What one research group calls a stressful life event, another may call a traumatic event, 
and some events may be included in one study but not another. 
 
 10 
1.3 Mechanisms of psychosocial stress and cognitive decline and dementia 
An important pathway through which psychosocial stressors may ultimately impact 
cognitive function and lead to dementia is through changes to the immune system elicited by 
chronic stress. Other established pathways include access to care and altered health behaviors. 
However, these pathways do not account for all of the variation in cognitive function, rate of 
cognitive decline, and incidence of dementia. Existing literature supports the theories that 
psychosocial stressors chronically activate the innate immune system through stress hormones 
and the hypothalamic-pituitary-adrenal (HPA) axis and this overactivation subsequently affects 
brain physiology. The biological mechanisms at play here are described in detail below. 
While the evidence that psychosocial stressors impact long-term health has existed for 
decades, only more recently have the biological mechanisms through which these stressors get 
under the skin and affect physiologic systems been elucidated. Research has shown a plausible 
mechanism by which psychosocial stressors elicit a neuroendocrine response to stress, operating 
through an activation of the HPA axis and the sympathetic nervous system (SNS).43 These 
associations are believed to operate through stress-induced neuroendocrine activation, leading to 
a release of pituitary and adrenal stress hormones including ACTH, catecholamines, prolactin, 
and cortisol.44 These hormones then alter immune function by either binding directly to immune 
cells, including T and B cells, mast cells, dendritic cells, macrophages, and natural killer cells,45 
or inducing dysregulation of cytokines, including IFN-γ, interleukin (IL)-1, IL-2, IL-6, and 
TNF.46,47 These mechanisms have been described in detail in the Infectious Disease chapter of 
The Routledge International Handbook of Psychosocial Epidemiology.48 The research described 
in this sections 1.3.a through 1.3.c summarizes evidence from that textbook chapter and 
highlights the abundant evidence supporting this pathway, specifically with regard to 
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socioeconomic disadvantage and lifetime stressors. It encompasses several relationships 
supporting these biologic mechanisms that may underlie the influence of stressors on immune 
function. Finally, section B3.d presents evidence supporting the biological mechanism through 
which immune function alters cognitive ability.  
1.3.a Psychosocial stressors and the innate immune system 
One biologic mechanism through which psychosocial stressors lead to cognitive decline 
and dementia is the innate immune system and inflammation. Many studies have examined the 
relationship between various psychosocial stressors and inflammatory markers such as C- 
Reactive Protein (CRP), IL-6, other interleukins, and Tumor Necrosis Factor (TNF) - α. 
Researchers have consistently demonstrated that these inflammatory markers are related to 
immune response.49,50 A 2007 review by Nazmi et al. found that many population-based studies 
demonstrated a statistically significant association between socioeconomic status (measured as 
education level, occupational status, income, or employment) and CRP.51 These variables were 
inversely related, with higher SES associated with lower levels of CRP. This relationship has 
been seen as early as childhood, suggesting that psychosocial stress can impact inflammation 
very early in the lifecourse.52 
However, research looking at stressors other than SES has yielded mixed results. Results 
from the Multi-ethnic Study of Atherosclerosis (MESA) showed that higher levels of chronic 
stressors were associated with higher levels of IL-6 and CRP,53 but when looking specifically at 
social isolation, Mezuk et al. found no statistically significant relationship with CRP.54 Yang et 
al. considered the importance of different stages of the life span in their research, finding that 
relationships between psychosocial stressors such as social integration, support, and strain and 
CRP varied depending on the life stage under consideration.55 This finding suggests that there 
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may be sensitive periods of exposure to stressors that alter the effect of those stressors on long-
term health. Herberth et al. found that SLEs were associated with cytokine levels. For example, 
parental divorce was associated with higher levels of IL-4 among 234 children while parental 
unemployment was associated with lower IFN-γ concentrations.56 In adults 50 an older who 
participated in the HRS, Elliot et al. found that lifetime trauma and chronic stress, and the level 
of control participants believed themselves to have over this stress, interacted to predict baseline 
levels and change over time in CRP levels.57 In the Heart and Soul Study, O’Donovan et al. 
found that high trauma exposure over the lifecourse was associated with higher levels of a 
composite score of IL-6, TNF-α, and CRP at both baseline and 5-year follow-up,58 and Lewis et 
al. found that older African Americans who experienced higher levels of “everyday” 
discrimination were more likely to have higher CRP levels.59  
1.3.b Psychosocial stressors and infections 
Another way this association between psychosocial stressors and immune dysfunction 
has been investigated is by looking at infection, specifically an individuals’ susceptibility to 
infection as well as one’s ability to control an infection once established. A person’s 
susceptibility to and ability to control an infection are further markers of the overall state of their 
immune system. A person who cannot efficiently suppress an infection, and therefore has a 
higher IgG response to that latent infection, is considered to have a more aged immune system. 
There are several ways that psychosocial stressors might affect one’s likelihood of having an 
infection, and these pathways have been outlined by Aiello et al.48 and are described in Figure 
1.1. First, those in low SES groups are more likely to be exposed due to things like crowding, 
environmental factors including their neighborhood and public sanitation, and health behaviors.60 
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Additionally, those in low SES groups 
might be more susceptible to infection 
through influences on innate and 
adaptive immunity, through genetic 
and epigenetic changes, or through 
influences of pre-existing 
comorbidities that can modify 
immunity.61,62  Finally, those in low 
SES groups may be less able to control 
infections once established due to modifications in immune response to existing chronic or latent 
infections, through impact on comorbidities, or through genetic and epigenetic changes. This 
may then lead to a decreased ability to control the infection.  
A number of studies have identified strong social gradients in the prevalence of a variety 
of common bacterial, viral and parasitic infections including influenza, herpesviruses,63-65 
Helicobacter pylori (H. pylori),65-67 and Toxoplasma gondii (T. gondii)65 beginning early in life 
and across the lifecourse. Beyond individual infections, psychosocial stressors, particularly 
financial strain, are also associated with a greater number of infections, including sums of 
seropositivity to various combinations of CMV, HSV-1, HAV, HBV, HSV-2, and H. pylori, 
beginning early in life and continuing through adulthood.63,68,69  
These are pathogens that establish latent infections in the body and are never cleared, but 
often cause no obvious symptoms, and research has suggested that these latent infections may 
actually have long-term negative health consequence through the following mechanisms: direct 
tissue destruction via localized inflammation, eliciting a local immune response but the immune 
Figure 1.1. Potential pathways through which psychosocial stressors 
may result in more infection. Adapted by Aiello and Zivich, from: Aiello et al. 
Psychosocial Influences on Infectious Disease. Chapter in: Kawachi, Steptoe, Kivimaki 




cells attack the local tissue;70 the triggered release of pro-inflammatory cytokines (innate 
immune response);71 and molecular mimicry, a process through which antibodies targeted 
against such pathogens may cross-react with and attack host tissues expressing homologous 
proteins.72 When immune control of these herpesviruses is weakened, the virus begins to 
replicate, which in turn stimulates memory B lymphocytes to increase output of virus-specific 
IgG antibody,73 causing increased antibody levels reflecting poorer immune control. 74,75 Studies 
have linked higher herpesvirus antibodies to a variety of stress exposures including academic 
stress in medical students and military cadets,76,77 caregiving for a family member with AD,78 
involvement in a poor quality marriage,79 anticipation of space flight by astronauts,80 ongoing 
financial or family issues,81 and early childhood adversity.82,83  
1.3.c Psychosocial stressors and the adaptive immune system 
Furthermore, psychosocial stressors have been shown to affect the adaptive immune 
system and potentially affect cognition and dementia risk through this pathway. The relationship 
between psychosocial stressors and immune dysfunction has been investigated by looking at 
measures of T cell phenotypes and immune system aging. Normal aging includes a clear decline 
in the adaptive immune system including decreased leukocyte production and function (e.g. 
reduced phagocytic capability of neutrophils, monocytes, and macrophages).84 The thymus 
gland, which plays a key role in immune function by producing naïve T cells, undergoes chronic 
involution after puberty, resulting in a decline in output with age.85 At the same time, reaction to 
the presence of pathogens across the lifecourse leads to an increasing proportion of memory and 
effector T cells and thus an increase in pathogen-specific, differentiated T cells.86 These 
differentiated cells become senescent with limited proliferative ability and upon viral stimulation 
generate a greater inflammatory response than less differentiated cells, further contributing to the 
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overactivation of the innate immune system described in section 1.3.a.87 Together these 
processes contribute to an immune phenotype in older age that is characterized by several 
alterations to the T cell compartment including an inverted ratio of CD4:CD8 T cells, a decrease 
in naïve T cells, and an accumulation of memory T cells with limited function combined with the 
effects on the innate immune system.88 
Several studies have suggested that low SEP and exposure to psychosocial stressors may 
be a key determinant of aging of the adaptive immune system across the lifecourse.89-91 A 2016 
study by Aiello et al. found that, among 79 middle-aged Detroit residents, for every $10,000 
decrease in income level, individuals had a 0.41 (95% CI: 0.09-0.72) and 0.20 (95% CI: 0.02-
0.39) log-unit increase in the ratio of effector to naïve CD4 and CD8 subsets, respectively.90 The 
authors note that these alterations are equivalent to an approximately 8- and 4-year increase in 
chronologic age of the immune system, respectively.90 Two other studies found further support 
for this association, with exposure to traumatic stressors or PTSD also being associated with T 
cell phenotypes.89,91 Copertaro et al. found that Italian nurses who received less social support 
had higher levels of circulating T-lymphocytes and TNF-α.92  
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There are thus several immune-specific mechanisms through which psychosocial 
stressors may act to alter cognition, and all of these pathways are broadly conceptualized as an 
“aged immune profile”. These pathways are visualized below in Figure 1.2. 
 
Figure 1.2. Biological mechanisms through which psychosocial stress may impact cognitive decline and incidence 
of dementia. 
 
1.3.d Immune dysfunction and cognition 
Recent evidence has implicated senescing immune cells and resulting inflammation as 
risk factors for both cognitive decline and AD.93,94 Several cross-sectional studies have shown 
that dementia patients have higher CRP levels in the blood compared to non-dementia patients,95-
99 as well as similar associations between CRP and cognitive level.100-103 Several longitudinal 
studies have corroborated this association, indicating that higher CRP is associated with an 
increased risk of AD104-106 and cognitive decline.103,104,107 However, both cross-sectional and 
longitudinal studies have shown mixed results, with several reporting no such associations108-114 
or an association between CRP and VaD but not AD.115 These associations and mixed results 
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have been seen with other inflammatory markers, including IL-6 and other interleukins,97,116-119 
TNF-α, 117,119-122 and CMV IgG response.123 However, inflammation is only one component of a 
senescing immune system. Other components such as the B- and T-cell profiles and immune 
control of latent infections may be just as critical to the pathology of cognitive decline and 
dementia. Despite the importance of considering the entire immune system, not only 
inflammation, few population-based studies have had the data to investigate the relationship 
between a senescent peripheral immune system and cognitive decline / dementia. 
This relationship between immune system aging and cognition is based on biological 
mechanisms that have been studied extensively in humans and animal models.93,124-131 As the 
human brain ages, the presence of misfolded proteins, free radicals, and epigenetic changes 
increase125,126 and microglia become senescent, leading to an elevation in the production of pro-
inflammatory cytokines, impaired phagocytosis, reduced motility, and reversing the 
demyelination of axons, which is a common change in neurodegenerative diseases.124,126,127 The 
presence of misfolded proteins (such as amyloid-	") elevates production of pro-inflammatory 
cytokines in microglia,93,125,126,128 but may additionally inhibit the ability of microglia to secrete 
anti-inflammatory cytokines. 126,129,130 However, there is also evidence that an inflammatory 
response activates microglia and astrocytes, leading to increased production of amyloid-β, and as 
such, it is unclear which is the triggering event for neurodegeneration leading to AD.124,131 
Studies comparing the immune profiles of individuals with AD to those of healthy 
controls have found evidence of advanced peripheral immunosenescence in individuals with AD, 
though these studies are small and results have been conflicting.132-134 Moreover, studies have 
found amyloid beta in the peripheral blood of individuals with AD. While advanced peripheral 
immunosenescence could itself be integral in the pathogenesis of dementia, it would require 
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accompanying perturbations in the blood brain barrier (BBB) to allow movement of immune 
molecules into the central nervous system (CNS). Disruptions in the BBB can lead to increased 
permeability allowing the transport of aged immune cells, inflammatory cytokines and 
chemokines, and infectious agents, all of which are critical to the disease process.  
As cytokines have neuromodulatory properties including roles in neurogenesis and 
neuronal survival,135,136 the imbalance of pro- and anti-inflammatory cytokines resulting from 
senescent microglia can lead to physiological changes in the brain. The overproduction and 
extended presence of pro-inflammatory cytokines in the brain can further damage the BBB,136 
which deteriorates naturally with increasing age.93 Leakage in the BBB has been observed 
early on in cases of AD93,137 and allows the passage of peripheral immune cells and 
inflammatory mediators into the central nervous system.124 While the BBB naturally 
deteriorates with age,93 environmental stimuli can also accelerate this process. However, it could 
be that the natural deterioration of the BBB that is in seen with age is in part driven by both 
peripheral and central immunosenescence. For example, as cytokines have neuromodulatory 
properties including roles in neurogenesis and neuronal survival,135,136 the imbalance of pro- and 
anti-inflammatory cytokines resulting from senescent microglia can lead to physiological 
changes in the brain. The overproduction and extended presence of pro-inflammatory cytokines 
in the brain can further damage the BBB.136 Specifically, IL-β activates IL-1 receptor 1 (IL-1R1), 
which can induce the deterioration of membrane phospholipids with as few as 2-3% of the 
receptors occupied.136,138 The imbalance of cytokines can alter neurotransmitter release, astrocyte 
function, and the activity of voltage-gated ion channels and receptor-coupled ion channels,136  
which has been shown to have long-term effects on cognition, such as impairing reversal 
learning,136,139 disrupting avoidance learning in adults,136,140 and altering neurotransmission and 
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plasticity in the hippocampus and pre-frontal cortex, though this evidence is largely of exposure 
to immune activation occurring during the prenatal period.136,141-145 
1.4 Psychosocial stress across the lifecourse  
Lifecourse epidemiology is the study of long-term biological, behavioral, and 
psychosocial processes that link adult health and disease risk to physical or social exposures 
acting during gestation, childhood, adolescence, earlier in adult life, or across generations.146 In 
the past three decades, the field of lifecourse epidemiology, emphasizing the importance of 
exposure timing, specifically at what time points across the life exposures have occurred, has 
come to prominence with respect to many health outcomes. Prenatal exposures, experiences in 
childhood, adolescence, and adulthood, may all differentially effect health outcomes as the body 
develops and declines. Three main theoretical models are typically used to conceptualize 
exposures across the lifecourse, which are relevant particularly to cognitive decline and 
dementia. The sensitive or critical period model posits that exposures acting during a specific 
period of time in the lifecourse may have lifelong effects which are not modified in any dramatic 
way by later life experiences.147 For example, exposure to traumatic events in childhood may 
result in a large impact on immune function, while exposure during midlife only results in 
moderate or small changes, theoretically. The accumulation of risks model, on the other hand, 
considers that exposure at all periods is important and that exposure gradually accumulates 
throughout life to compound the effect on health outcomes. As the number, duration, and 
severity of exposures increase, there is increasing cumulative damage to biological systems. 
Finally, the chains of risk (or pathway) model hypothesizes that the trajectory of experiences 
across the lifecourse will have the most effect on biological systems, that events experienced 
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early in life may set one upon a track, or set in motion a chain reaction, of exposures that effect 
biological systems later in life.148 
Lifecourse theory is particularly applicable to the research area of psychosocial stress and 
cognition as we have seen that the timing of other established dementia risk factors matters to 
how and how much those factors affect cognition and dementia. The adult brain structure is 
primarily determined during childhood,149 and as such, social and environmental exposures 
occurring during this developmentally important period may be especially influential on later life 
cognitive trajectories and dementia incidence. In fact, many studies have investigated early life 
genetic factors, childhood intellect, early life SES, physical development, and childhood 
adversity and their association with cognition and dementia. A 2015 review by Seifan et al. 
thoroughly summarizes the evidence of early-life social and environmental factors and their 
effect on AD.150 The authors highlight that the evidence of early-life SES’s effect on AD is 
uncertain; there have been studies finding that early-life socioeconomic disadvantage is 
associated with a higher risk of AD, but also there have been as many studies finding no 
association. More recently, Donley et al. found that childhood stress including living in an 
orphanage, experiencing a crisis, and emigrating, among men, was associated with 1.86 times the 
hazard of being diagnosed with dementia over 25 years of follow-up.151 This is important as 
socioeconomic disadvantage is considered a psychosocial stressor and would likely activate the 
same pathways as the other stressors discussed here. Additionally, the effect of early-life stress 
on cognitive function is well established, finding that early-life disadvantage and traumatic 
experiences are associated with diminished cognitive function later in childhood.152 However, 
there is limited research into the effects on cognitive decline and dementia incidence in old age. 
One study found that maternal death in childhood was associated with two times the likelihood 
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of AD in late life,153 and another found differential effects of early-life adversity on cognitive 
decline by race.154  
Further indications that early-life SLEs may impact cognitive decline and dementia risk 
come from evidence that early-life SLEs alter immune system development and later life 
immune function, a key mediator along the proposed pathway. Stress during early childhood is 
also hypothesized to be a sensitive period for immune system development,155,156 including the 
production and function of numerous immune cells and regulation of inflammatory responses. 
Studies have demonstrated that individuals who experience greater socioeconomic disadvantage 
during the prenatal period or in childhood have poorer immune function in young- to late-
adulthood, including increased susceptibility to respiratory infections.157 elevated levels of pro-
inflammatory markers,158 and decreased expression of genes that serve to regulate 
inflammation,159 irrespective of later life SES. There is also indication, however, that the effect 
of psychosocial stress on immune function follows a chain of risk model, with early life exposure 
being mediated through later life exposures to psychosocial stress. For example, a 2016 study 
among U.S Latinos found that the effect of early-life SEP on immune response to persistent 
pathogens was mediated by later life SEP, including educational attainment and occupation in 
the model.160   
No studies, to our knowledge, have directly compared the effect of traumatic events or 
major experiences of discrimination experienced in adulthood to the effect of these events 
experienced in childhood on cognitive decline and dementia incidence. Furthermore, no studies 
have distinguished between early adulthood, mid-life, and late-life in their exposure assessment 
for analysis. Prior studies focused on adult exposures often only investigate psychosocial 
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stressors experienced recently, i.e. within the past few weeks or years, rather than across the 
entire lifecourse. 
1.5 Cognitive reserve 
The cognitive reserve hypothesis theorizes that the human brain can cope with damage 
differentially by certain factors, including educational attainment and income, and that 
intelligence can protect an individual from the changes in brain pathology that lead to cognitive 
decline.161 This hypothesis was born from extensive evidence that there is not a consistent 
relationship between the degree to which brain pathology progresses toward characteristic 
dementia pathology and the degree to which cognitive abilities decline. Cognitive reserve, in 
theory, accounts for this discrepancy: those with worse pathology who exhibit less cognitive 
decline are able to do so because of their cognitive reserve.  
Reserve, or the factors allowing the brain to cope with damage differentially, can be 
thought of in two ways: as either a passive process in which there is a threshold past which the 
degeneration is expressed clinically, or an active process in which the brain is constantly 
working to compensate for degeneration. The passive models conceptualize this as “brain 
reserve” in which the brain size, number of synapses, etc. (i.e. the “hardware” of the brain) are 
the “reserve”, and the degradation of these occurs and there is a “critical threshold” at which 
functional deficits manifest themselves clinically.13,162 Thus, theoretically, the more “brain 
reserve” one starts with, the more degradation he/she can sustain before reaching clinical 
impairment. The active models, on the other hand, conceptualize “cognitive reserve” as “the 
ability to optimize or maximize performance through differential recruitment of brain networks, 
which perhaps reflect the use of alternative cognitive strategies.”13 This “software” hypothesis 
theorizes that reserve allows someone to process information and tasks more efficiently, and 
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therefore the same amount of degradation in brain physiology may not manifest in the same 
clinical symptoms.13 It is used to explain the phenomenon of a lack of consistent relationship 
between brain damage and clinical manifestation of cognitive deficits as those with higher levels 
of intelligence or education or occupational attainment being able to sustain more physiologic 
damage before deficits in cognition manifest themselves. The biological basis of this idea is that 
some people are able to use their brain physiology more efficiently if they need to, so rather than 
having more synapses, they instead recruit existing synapses more efficiently when needed in the 
wake of brain damage. This ultimately means that even if two individuals sustain the same 
amount of brain damage, one with more cognitive reserve (i.e. a greater ability to recruit brain 
networks efficiently) will present fewer clinical cognitive deficits (or none) because of his/her 
reserve. 
Due to the association between educational attainment and brain processing, cognitive 
reserve is often proxy measured in studies by level of educational attainment. There is still, 
however, debate in the literature as to whether educational attainment is protective of 
neurodegeneration or merely compensates for that degeneration.163 Bosma et al. found that 
mentally demanding work was associated with slower cognitive decline and delayed onset of 
dementia in adults.164 However, Zahodne et al., and other studies, have found that higher 
education level does not slow the rate of cognitive decline.165 In a recent study by Bruandet et al., 
greater cognitive reserve as measured by education level was protective against onset of decline 
but was ultimately associated with a higher rate of cognitive decline, among individuals with AD 
who were followed for 3.5 years.12  
There are clear limitations to using educational attainment as a proxy measure for 
cognitive reserve, particularly in research about psychosocial stressors. Educational attainment, a 
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common marker of socioeconomic status, is in itself, a marker of psychosocial stress. 
Additionally, while these associations between educational attainment and rate of decline have 
been seen, we do not know whether educational attainment is associated with any brain 
pathology or how it is associated processing, therefore our ability to understand how we’re 
investigating the “hardware” and “software” cognitive reserve hypotheses is very limited. This 
will possibly result in bias in study results due to measurement error. Furthermore, educational 
attainment, categorized by degree, will likely have large variation within each category as well as 
between categories. As psychosocial stressors may accelerate neurodegeneration, and cognitive 
reserve may alter the clinical presentation of cognitive impairment, we hypothesize that stressors 
and educational attainment interact to modify the relationship between stressors and an 
individual’s cognitive decline trajectory and risk of dementia. 
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1.6 Conceptual framework 
This dissertation is based on the conceptual framework described in Figure 1.3. In this 
conceptual framework, adult psychosocial stressors are associated with cognitive decline and 
incident dementia via immune system aging, health behaviors, access to healthcare, and potential 
other factors. Stressors experienced during childhood are associated with adulthood stressors and 
ultimate cognitive decline and dementia through this pathway as well as through educational 
attainment/cognitive reserve. We conceptualize cognitive reserve (proxy measured by 
educational attainment) as both a confounder and effect measure modified of the proposed 
relationship between immune system aging and cognitive decline and dementia. Furthermore, we 
conceptualize cortisol, a stress biomarker, as a mediator of the stressor – immune function 
























Figure 1.3. Conceptual framework for this dissertation, showing the relationship between psychosocial stressors SLEs, 
perceived discrimination, and ongoing stress on cognitive decline and dementia, with the mediator of the inflammatory 
immune response. [U] indicates unknown or unmeasured factors, and [Z] indicates all remaining confounding factors 
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outcomes. [U] represents unknown factors that confound the relationship between childhood and 
adulthood stressors, while [Z] represents a set of confounders of the adulthood stressor – 
cognitive decline and dementia relationship, including demographic factors such as age and 
biological sex. 
1.7 Significance 
The proportion of U.S. population over the age of 65 is growing rapidly as life 
expectancy increases and births decline, and with this aging population come increased concerns 
regarding the long term health and cognitive abilities of the elderly.166,167 Functional and 
cognitive aging present a 
unique health care challenge 
for the country, as the 
increase in the likelihood of 
decline of cognitive ability in 
elderly populations leading to 
substantial cognitive 
impairment and both VaD 
and AD, affects an estimated 5.2 million people over 65 years in the U.S. as of 2016.1 In 2016 
alone, the U.S. spent $162.7 billion on long-term healthcare, which is approximately 5% of all 
U.S. healthcare costs.168 As previously mentioned, this burden will only continue to grow 
through the next several decades, with an estimated 14 million cases of AD projected in the U.S. 
by 2050, underscoring the importance of long term, preventive measures. These cases will 
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Figure 1.4. Projected number of individuals with AD in the United States by age 
group and year. Projection numbers obtained from Hebert et al.1  
 
 27 
living/long-term care industry. Geriatricians and caregivers for the elderly are already in high 
demand, and this demand will continue to grow for the foreseeable future. 
Besides introducing a new burden on the healthcare system simply by requiring extensive 
care for routine activities, those suffering from dementia are at an elevated risk of several other 
negative health outcomes due to their increased risk of exposure to infections and diminished 
ability to care for themselves, contributing significantly to healthcare costs.169 Those suffering 
from dementia and other memory disorders are more likely to have comorbidities such as 
diabetes, infection, injury, and depression.170-172 All of these secondary health conditions that 
occur partially as a result of the cognitive and functional impairment of the elderly exert an 
additional burden on the healthcare system. As such, it is imperative that aging researchers 
investigate determinants of dementias. We must look into what factors either accelerate cognitive 
decline, increase risk of dementia, or both, in order to identify potential targets for intervention 
and prevention. 
The interest of this dissertation lies in the psychosocial risk factors for cognitive decline 
and dementia and in the immune mechanisms through which these risk factors affect long term 
cognitive health. We know there is significant heterogeneity in the rate at which individuals’ 
brain function declines and the age at which this decline crosses the threshold into clinical 
cognitive impairment. If psychosocial stressors—specific stressors or any stressors in general—
prove to be meaningful risk factors for accelerated decline and dementia incidence, they, their 
timing, and the pathways through which they act can become targets for intervention. While 
psychosocial stress cannot be wholly prevented in practicality, interventions designed to reduce 
these stressors are feasible, and would warrant further investigation if our hypotheses are 
supported. Additionally, immune function mediators could be another target for intervention, as 
 
 28 
any point on the path to cognitive decline and dementia presents an opportunity for delay of 
decline and onset. Given the large disparities in experienced stress across the U.S., it is important 
to clearly understand these associations in order to optimize prevention strategies. 
If our hypotheses are supported, our results will have major implications for the 
prevention of cognitive decline and onset of dementia in elderly populations. As dementia is a 
progressive disease, prevention prior to onset is essential to reducing the subsequent health care 
burdens. Our results could provide new avenues to pursue for delay and prevention of these 
conditions, and lead to a higher quality end-of-life period for many people. Furthermore, 
identification of early life experiences as a sensitive period for the influence of traumatic events 
on dementia risk would provide a specific life period to focus preventive efforts in. Additionally, 
identification of educational attainment as a modifier and immune function as a mediator of the 
relationships would provide further insight into cognitive processes. Understanding the 
mechanisms through which these social and environmental factors may interact to affect 
cognitive decline and onset of dementia will move the field forward and allow us to design 
targeted interventions to reduce disparities in and the overall incidence of dementia. 
1.8 Innovation 
The high and increasing burden of cognitive impairment and dementia in the U.S. is not 
adequately explained by established cognitive risk factors. However, psychosocial stressors 
accumulated across the lifecourse have been identified as potential factors contributing to 
cognitive decline and dementia. These are dynamic factors that accumulate over the lifecourse, 
especially among those of lower social status. However, the role of psychosocial stressors 
including traumatic events and discrimination, on cognitive decline and dementia incidence have 
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not been thoroughly explored and no scientific consensus has been established. This dissertation 
is therefore innovative because: 
1) Much of the prior research into these relationships has been limited by small sample 
sizes15,22,23,31,37-39 and restricted populations.14,16,17,33,37,173 This study is the first large-
scale population-based investigation into these processes. The HRS is designed to be 
nationally representative of the over 50 years old population in the U.S. and includes 
data from 9,550 eligible individuals. 
2) Most of the prior research has focuses on a regarding psychosocial stressors and 
cognition utilizes limited measures of psychosocial stress in that they do not 
incorporate information on when in the lifecourse the stressor occurred. Most studies 
focus on either childhood-specific events only,14,20 very recent events,38 or events at 
any point with no consideration given to the timing of those events.174,175 This study 
utilizes rich psychosocial data obtained via mail-in survey. This psychosocial 
questionnaire covers several substantive areas including lifestyle and experience of 
stress, and importantly asks questions regarding when these experiences occurred. 
With this detailed data on our psychosocial stressors of interest, we were able to 
a. consider an important dimension of psychosocial stressor: traumatic events, 
and 
b. identify which life period the events took place in and investigate whether 
stressors follow the accumulation of risk model, sensitive period model, or 
trajectory model in their effects. 
3) Existing studies of traumatic events and cognition have investigated cognitive decline 
over much shorter periods of time, from six months to a few years, with only one, the 
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longest, including up to eight years of follow-up.21 Most of the previous research is 
therefore limited in temporal inference and power to detect change over time. Our 
study will overcome this major limitation by utilizing up to 10 years of follow-up data 
giving us detailed cognitive trajectory information on thousands of participants and a 
long period in which to accumulate cases of dementia. Our data, while not a full 10 
years for each participant, gave us a time frame during which significant cognitive 
decline can occur in a single individual as well as significant diversion in cognitive 
decline trajectory can occur among participants. 
The interplay of psychosocial stressors with immunity across the lifecourse and among 
the elderly is potentially of enormous importance in elucidating how multiple dimensions of 
stress across impact cognitive health. However, investigation of this interplay is limited in the 
current literature. This study is the first to examine the dynamic relationships between 
psychosocial stress, immunosenescence, and cognition, incorporating retrospectively collected 
psychosocial stress data covering the lifecourse, with up to 10 years of follow-up, in a large, 
U.S.-representative cohort, in order to gain a more comprehensive understanding of how these 




CHAPTER 2: STATEMENT OF SPECIFIC AIMS 
 This project seeks to improve our understanding of the pathophysiology of cognitive 
decline and dementias, and specifically the role of psychosocial stressors in this process. The 
proportion of the U.S. population over 65 years old is growing rapidly,166,167 which presents a 
unique health care challenge for the country. The likelihood of decline of cognitive function is 
increased in elderly populations, leading to substantial amounts of cognitive impairment and thus 
both vascular dementia (VaD) and Alzheimer’s Disease (AD), with an estimated 5.2 million 
people over 65 years in the U.S. suffering from AD as of 2016.1 Those suffering from any type 
of dementia are at an elevated risk of several other negative health outcomes due to a diminished 
ability to care for themselves, contributing significantly to healthcare costs.169 Therefore, 
preventing or postponing the onset of dementia is now an explicit research priority for the NIH 
and the CDC,176 but in order to achieve that goal we must improve our understanding of factors 
contributing to cognitive decline and dementia.  
Cognitive decline is a normal phenomenon: as we age, our reasoning, memory, and 
processing speed begin to decline, and our brains physically change by decreasing grey matter 
volume, forming β-amyloid plaques, and experiencing neuronal cell death.177 However, there is 
significant heterogeneity in the rate at which individuals’ brain function declines and the age at 
which this decline crosses the threshold into clinical cognitive impairment. Hypotheses for the 
origin of these disparities include both lifestyle and genetic factors, which have been shown to 
contribute to decline,2 but much of the variance remains unexplained. Furthermore, the rate of 
decline and onset of clinical symptoms of cognitive impairment may be modified by cognitive 
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reserve, a reflection of an individual’s capacity for compensation of cognitive deficits. We 
propose that psychosocial stressors experienced across the lifecourse explain a significant 
proportion of the heterogeneity in cognitive decline and dementia incidence, and the relationship 
may be modified by cognitive reserve. 
One likely mechanism through which psychosocial stressors impact cognition is immune 
system alterations. Several studies have demonstrated the association between psychosocial 
stressors and immune dysfunction, finding that higher levels of chronic stressors are associated 
with higher levels of inflammatory markers such as IL-6 and C-reactive protein (CRP).53,56-59 
However, other studies have found that results may depend on stage in the lifecourse of 
exposure, and that some immune biomarkers are not associated with exposure, highlighting the 
need for further research.55 Furthermore, while it is widely accepted that inflammation in the 
central nervous system (CNS) plays a critical role in the pathogenesis of dementia, less is known 
about the role of the peripheral immune system. Studies comparing the immune profiles of 
individuals with AD to those of healthy controls have found evidence of advanced peripheral 
immunosenescence in individuals with AD, and advanced peripheral immunosenescence could 
itself be integral in the pathogenesis of AD.126,178 Disruptions in the BBB from dysregulation of 
cytokines can lead to increased permeability allowing the transport of aged immune cells, 
inflammatory cytokines and chemokines, as well as infectious agents all of which are critical to 
the disease process leading to cognitive decline and dementia. Despite the potential importance 
of these links, few studies have longitudinally investigated the relationships between 
psychosocial stressors, the peripheral immune system, and cognitive decline and dementia.  
AIM 1a. Estimate the association of traumatic life events (e.g. death of a child) with cognitive 
trajectories and incidence of dementia over 10 years of follow-up.  
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AIM 1b. Investigate whether educational attainment, a possible marker of cognitive reserve, 
modifies the association between lifetime stressors defined in Aim 1a and cognitive decline and 
incidence of dementia. 
AIM 2a. Evaluate the association of cytokines and IgG response to persistent infections, as 
measures of immune function, with cognitive trajectory and incidence of dementia in an elderly, 
Latino population. 
AIM 2b. Investigate whether salivary cortisol, a key stress hormone, interacts with the above 
markers of immune function to alter cognitive trajectory. 
AIM 2c. Investigate whether educational attainment, a possible marker of cognitive reserve, 
modifies the association between biomarkers defined in Aim 2a and cognitive decline. 
We use data from the Health and Retirement Study (HRS) and the Sacramento Area 
Latino Study of Aging (SALSA) to investigate the effect of lifetime traumatic events, and 
perceived discrimination prior to baseline on the trajectory of global cognition and incidence of 
dementia. Using the in-depth Psychosocial and Lifestyle Questionnaire data collected in 2006 
and 2008 from the HRS, we investigate two domains of psychosocial stress—applying three 
lifecourse frameworks, the accumulation of risk, sensitive period, and trajectory models—and 
several biomarkers of immunological aging. Using data on infection and cognition in SALSA, 




CHAPTER 3: METHODS 
3.1 Study Design 
Our proposed project will utilize data derived from two large longitudinal cohort studies: 
The Health and Retirement Study (HRS) and the Sacramento Area Latino Study of Aging 
(SALSA). The original goal of HRS was to collect longitudinal data on aging processes in a 
U.S.-representative cohort of adults over the age of 50 years. Participants are interviewed every 
two years, and every 6 years a new group is enrolled to enrich the cohort. During the biennial 
interviews, participants answer questions regarding demographic information, socioeconomic 
status, health conditions, and complete the Telephone Interview for Cognitive Status (TICS). 
HRS participants additionally retrospectively reported myriad information on psychosocial 
stressors and lifestyle experiences across their lifecourse. The study is ongoing at present and has 
completed 13 waves of follow-up from 1992 to 2016. The second longitudinal study we will use, 
SALSA, had original goals to identify vascular, metabolic, and sociocultural predictors of 
dementia, mortality, and cognitive decline among elderly Latinos.179 SALSA participants 
additionally provided blood samples which were tested for persistent infections and cortisol. The 
study completed seven waves of follow-up from 1998 to 2008. 
All aims will use a longitudinal cohort study design. Those participants who were 
dementia-free at baseline are eligible for inclusion in our analyses. For aims 1a and 1b, we will 
create an analysis cohort using the HRS, with baseline at either the 2006 or 2008 interview, 
depending on when the participant answered the Psychosocial and Lifestyle Questionnaire. Data 
will include cognitive follow-up through 2016. For aims 2a, 2b, and 2c, we will use SALSA to 
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create an analysis cohort of those who were dementia-free at baseline and consented to collection 
of blood during baseline interviews. Data from SALSA are geocoded and representative of 
Latinos residing in the Sacramento Valley, allowing for examination of neighborhood effects. 
3.2 Study Population  
The Health and Retirement Study (HRS) 
The proposed research will use data from the HRS, the largest on-going nationally 
representative longitudinal survey of older adults in the U.S., conducted at the University of 
Michigan. HRS began in 1992 and included over 22,000 adults over the age of 50 years at 
baseline. Follow-up occurred, and continues to occur, every two years. Using a national area 
probability sample of U.S. households, with supplemental oversamples of racial minorities, the 
HRS selected households based on a multi-stage area probability design. The primary sampling 
stage used a probability proportionate to size selection of U.S. Metropolitan Statistical Areas and 
non-MSA counties, the second stage sampling of area segments. The third stage selected from an 
enumerated list of all housing units within the areas selected in stage 2, and the final stage was 
the selection of the household within a sample housing unit.180 Of those contacted in wave 1, 
81.6% responded, and subsequent response rates remained in the mid-to-high eighties.181 Data 
collection consisted of face-to-face baseline interviews and primarily telephone interviews for 
follow-up waves, until 2006, at which point half of the sample was randomly assigned face-to-
face interviews to enhance physical and biological measures. The half receiving face-to-face 
interviews alternated at each subsequent wave.181 
Our analyses will use existing demographic, and cognitive data from the 2004 through 
2016 waves, with psychosocial data from the 2006 and 2008 waves’ Psychosocial and Lifestyle 
Questionnaire. The Psychosocial and Lifestyle Questionnaire, which collected data on lifestyle 
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and stress, quality of social ties, personality, work-related believes, subjective wellbeing, and 
self-related beliefs is a self-administered questionnaire that was piloted in 2004 and fully 
implemented in 2006, 2008, and 2010. A random 50% of the core panel participants who were 
chosen to receive the face-to-face interview in 2006 were given the Psychosocial and Lifestyle 
Questionnaire, with the other 50% receiving the questionnaire in 2008. Questionnaires were left 
with participants at the end of their face-to-face interview, who completed and returned the 
questionnaire to the study team via mail. 90% of recipients completed the 2006 questionnaire, 
and factoring in the 90% response rate of the interviews, the overall response rate was 74%. The 
2008 survey had a response rate of about 80%, and factoring in the interview response rate of 
88.4%, overall response was about 71%.182 
All those who completed either the 2006 or 2008 Psychosocial and Lifestyle 
Questionnaire will be included in the analysis for aim 1 (n=7,785). See Table 4.1 for 
demographic details of the study population. Weights provided by the HRS for the Psychosocial 
and Lifestyle Questionnaire respondents will be used to create a U.S.-representative study 
population. 
The Sacramento Area Latino Study of Aging (SALSA) 
Aims 3a and 3b will utilize a subsample of data from SALSA. SALSA is a prospective, 
observational community-based cohort study of 1,789 self-designated Latino adults in the 
Sacramento Valley, CA area who were aged 60 years or older at baseline. We will use a 
subsample of 1,204 participants who gave blood and had at least two sequential follow-up visits. 
The sample is highly representative of older Hispanics living in the area, and more than 89% of 
eligible households had at least one member participate. Participants were contacted by mail, 
phone, and finally door-to-door neighborhood visits, with up to ten attempts via phone and five 
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attempts at the home allowed.179 Approximately 22% of the total eligible population of 
Sacramento county was recruited. Staff bilingual in Spanish and English conducted baseline 2-
hour interviews at the participants’ homes during 1998-1999. The interview included questions 
regarding lifestyle factors, depressive symptoms, acculturation, and medical diagnoses. Blood 
pressure was taken, and blood samples were drawn, in addition to buccal swabs for DNA. 
Follow-up visits occurred every 12-15 months, with a total of 7 follow-up visits over 10 years, 
during which participants reported health conditions and lifestyle and sociodemographic risk 
factors, and completed a cognitive evaluation.179  
3.3 Outcome Assessment 
Cognitive Function. In HRS, global cognition is a summary variable based on several 
cognitive tests including word recall and mental status items. Questions included in this score 
were asked over telephone by interviewers as part of Telephone Interview for Cognitive Status 
(TICS) and were answered by the study participant. This variable has a possible range of 0-35, 
and includes immediate recall (0-10), delayed recall (0-10), serial 7s (0-5), backwards count 
from 20 (0-2) + object naming (scissors & cactus; 0-2) + President naming (0-1) + Vice 
President naming (0-1) + date naming (month, day, year, day of week; 0-4) encompassing 
cognitive domains of verbal memory, orientation, and executive functioning and attention. The 
TICS cognitive score will be treated as a continuous measure in analyses. 
In SALSA, global cognition was measured at baseline and each follow-up visit using the 
modified Mini-Mental State Examination (3MSE).34 This exam, designed to assess cognitive 
ability among the elderly while being easy to administer and while providing objective scoring, 
is widely used in cognitive research and has been validated.60 The 3MSE tests a variety of 
cognitive abilities including recall, attention and calculation, registration, and orientation to time 
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and place and is a common measure of cognitive ability in our populations. With 30 questions 
total, each varying in score value but with greater granularity than the MMSE, the 3MSE has a 
final score range of 0 – 100, a sum of each individual question’s score, and is able to detect more 
nuance than the previously used MMSE.34,61 We expect the distribution of scores to be 
negatively skewed and thus will apply a logarithmic transformation for analysis. The 3MSE was 
administered as part of the home interviews.59 
Dementia. In HRS, there is no formal clinician-adjudicated diagnosis of dementia or 
specific subtypes of dementia. Therefore, we will utilize an approach previously described by 
Hurd et al.183 and modified for disparities research by Gianattasio et al.,184 which uses existing 
data collected from each wave to categorize participants as having dementia or not. The Hurd et 
al. paper takes the biannually collected cognition data (TICS) and combines that with data on 
participants’ functional limitations. The TICS score, described above, will be incorporated. Data 
on six activities of daily living (ADLs), including eating, transferring, toileting, dressing, 
bathing, and walking across a room, and five instrumental activities of daily living (preparing 
meals, grocery shopping, making telephone calls, taking medications, and managing money) are 
also collected in HRS and used in this paper.185 Hurd et al. further used age, educational level, 
sex, and change in ADLs, IADLs, and TICS in a model to predict dementia. This method also 
allows us to continue using data on those participants who have transferred to proxy interviews 
due to inability to complete the study interviews. In these cases of a proxy interview, the 
Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE),186,187 a validated 
instrument of 16 questions about memory and functional ability of the participant, responses will 
be incorporated.  
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Model specifications from this study are provided in their studies’ Supplementary 
Materials. The first step in the Hurd et al. analysis was to use ADAMS participants to generate a 
statistical prediction model. They used ordered probit regression models incorporating the 
previously stated variables as independent variables and dementia status (normal, CIND, 
demented) as the outcome. Beta coefficients from these models were reported and then used first 
within the ADAMS sample and then on the full HRS sample to predict dementia. A participant 
was designated as having dementia if the fitted probability of dementia was greater than the 
probability of normal aging or CIND. By comparing their model-based predictions within 
ADAMS to the clinical diagnoses, they determined that this method had a sensitivity of 77.9% 
and a specificity of 89.8%.183 Then, Gianattasio et al. improve the sensitivity and specificity of 
this measure by identifying specific cutpoints for each racial and ethnic group represented in the 
data. Separate models were used for those with data provided by proxy. 
We took this tool one step further and only defined someone has having incident 
dementia if they remained below this threshold for the remainder of their follow-up time in the 
study. If someone goes back and forth over the threshold over time, this likely is not a case of 
dementia but rather of low cognition. Finally, beginning in 2010, HRS incorporated the 
following question into the participant interview: “Has a doctor ever told you that you have 
Alzheimer’s Disease?” An affirmative response to this question at a given wave was used to 
confirm incident diagnoses of dementia or identify any missed by the algorithm.  
In SALSA, clinical diagnosis of dementia was a multistage process beginning if 
participants scored below the 20th percentile on the 3MSE or their score lowered by >8 points 
since the previous exam. These participants were referred to take a neuropsychological test 
battery and were further referred to neuropsychologists if they received a score below the 
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specified cutoffs. A neuropsychologist or neurologist then diagnosed type of dementia based on 
the National Institute of Neurological and Communicative Disorders and Stroke and the 
Alzheimer’s Disease and Related Disorders Association criteria.188 
3.4 Exposure Assessment 
Exposure data was obtained from the leave-behind Psychosocial and Lifestyle 
Questionnaire in the HRS. This questionnaire was introduced in 2004 and was restricted to a 
50% random sample each year with the same sample of respondents re-interviewed in alternate 
waves. The 50% of participants who did not receive the questionnaire in 2004 received it in 
2006, and then the original 50% again in 2008. We used responses from the 2006 and 2008 
waves of data collection in order to take advantage of the expanded survey questions. In 2006, 
the overall response rate was 74% of those who were assigned to the EFTF interview, and in 
2008, the response rate was 71% of those assigned to the EFTF. The questionnaire was left 
behind by interviewers and completed by the participant who then mailed the questionnaire back 
to the HRS research team. We used traumatic events as the stressors of interest in this study.  
3.4.a Lifetime Traumatic Events 
Lifetime Traumas: Participants were asked 7-item checklist which was developed for an 
ongoing study of the health consequences of trauma in older adults from several sources.189 The 
following questions were asked after the prompt “For each of the following events, please 
indicate whether the event occurred at any point in your life. If the event did happen, please 
indicate the year in which it happened most recently”: 1) Has a child of yours ever died? 2) Have 
you ever been in a major fire, flood, earthquake, or other natural disaster? 3) Have you ever fired 
a weapon in combat or been fired upon in combat? 4) Has your spouse, partner, or child ever 
been addicted to drugs or alcohol? 5) Were you the victim of a serious physical attack or assault 
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in your life? 6) Did you ever have a life-threatening illness or accident? 7) Did your spouse or a 
child of yours ever have a life-threatening illness. We manually added an eighth component to 
this measure, the death of a spouse, by counting those whose marital status is ‘widowed’ as an 
affirmative response to an eighth question.  
A cumulative measure of lifetime trauma was created by summing all of the affirmative 
responses occurring across the lifecourse. If participants answered yes to any of the stressful 
event questions, they were then asked “In what year did this event occur?” This information 
allowed us to create life period-specific measures of trauma, as well. 
Lifetime Traumas before the age of 18: Participants were asked the following 
questions, from the same source as the Lifetime Traumas checklist, with the prompt of “For the 
next set of events, please think about your childhood growing up, before you were 18 years old”: 
1) Before you were 18 years old, did you have to do a year of school over again? 2) Before you 
were 18 years old, were you ever in trouble with the police? And 3) Before you were 18 years 
old, did either of your parents drink or use drugs so often that it caused problems in the family? 
A measure of childhood trauma will be created by summing the affirmative responses to the 
latter two. The first question was not included due to its correlation with cognitive function. 
Using the two measures described above, we created a) an overall continuous measure of 
traumatic events experienced across the lifecourse and b) a life period-specific continuous 
measure of traumatic events experienced. We combined the scores from each set of questions for 
the overall. For the life period-specific measure, we will create variables for childhood (ages 0 – 




In SALSA, blood samples were collected from participants in their homes by trained 
phlebotomists and transferred on ice to be processed. Serum samples have since been stored 
continuously frozen at -70 ºC, and this storage protocol has been proven to have minimal effects 
on reliability of measurements conducted at later time points, with antibodies to these viruses 
stable over time when continuously frozen.190 
Infection. For virus data (HSV-1, HSV-2, CMV, and VZV in SALSA), baseline blood 
serum samples were analyzed for level of IgG antibodies to the specified pathogen using 
enzyme-linked immunosorbent assays (ELISA). Through a series of incubation and wash steps, 
the antibodies specific to our viruses of interest will link to antibodies present in our samples and 
then to a secondary reactive antibody. These assays will generate values on a continuous scale, 
reported as optical density (OD) units, that correspond to the level of IgG antibodies in the blood. 
In addition to the continuous measurement of IgG response, the laboratory determined whether 
each sample is seropositive or seronegative for each virus based on established cutoffs of IgG 
response. Each commercial ELISA kit contained controls and internal calibrations. IgG 
responses were standardized to a normal distribution with a mean of 0 and standard deviation of 
1 prior to use in analyses. 
Innate immune function. SALSA contains data collected from baseline blood serum 
samples on the following cytokines: IL-6, CRP, and TNF-alpha. We examined each cytokine 
individually, modelled as continuous and dichotomized at the mean, within SALSA, to classify 
individuals according to inflammation. 
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3.5 Covariate Assessment  
In the HRS, sociodemographic data including educational attainment, sex, age, existing 
comorbidities, income, marital status, and race/ethnicity were taken from the participant’s 
baseline survey years, either 2006 or 2008. These data were self-reported during interviews 
conducted by trained study staff, in the participants home, as each person has as baseline the year 
during which they were given a F2F interview. In the SALSA, educational attainment, sex, age, 
existing comorbidities, income, marital status, and other demographic characteristics were self-
reported during baseline interviews conducted by trained study staff in the participants’ homes. 
Educational attainment was reported as the number of years attended. For the effect measure 
modification analysis, education in HRS was categorized as less than high school, high school 
diploma & some college, college degree, and graduate study. In SALSA, education was 
categorized as < 8th grade, some high school, and high school diploma or more education. The 
measures are thus based on the highest degree obtained.  
3.6 Statistical Analyses 
As a first step for all aims, directed acyclic graphs (DAG) were developed to assist our 
choice of control covariates (Figures 3.1 and 3.2).191 Variables identified as potential 
confounders in a minimally-sufficient adjustment set were used to create IP weights to control 
for confounding  in regression analyses. Potential effect measure modifiers (not shown in DAGs) 
were included as interaction terms and investigated separately in stratified regression models. 
We did not adjust for any potential mediators in our analyses due to the methodological 
complications of adjusting for variables that are along the causal pathway between the outcome 
and exposure.192,193 Evidence suggests that psychosocial stressors influence depression and 
health behaviors, therefore these were not adjusted for in Aim 1 as we consider them to be 
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mediators of the exposure-outcome relationship of interest. The distributions of participant 
demographic, socioeconomic, psychosocial, immunological, and cognitive characteristics were 
summarized with descriptive analyses at the outset of each aim. All statistical analyses were 
completed in SAS 9.4 (Cary, NC) and figures were created in R. 
AIM 1a. Estimate the effects of lifetime perceived discrimination and traumatic 
events (e.g. death of a child) on cognitive trajectory and incidence of dementia over 10 
years of follow-up. The goal of this aim is to test whether lifecourse experiences of 
discrimination and traumatic events over the lifecourse are associated with accelerated cognitive 
decline and incident 
dementia. Exposure 
variables: 1) Sum score of 
lifetime trauma, categorized 
as 0 events, 1 event, or 2+ 
events; 2) Lifecourse 
period-specific sum scores 
of the psychosocial 
stressors, categorized as 
described above. Outcome 
variables: Both incident 
dementia and cognitive trajectories were explored as outcomes. Covariates: To address potential 
confounding, covariates were assessed a priori via DAG analysis and a minimally sufficient 
adjustment set was selected for inclusion in a model to create inverse probability of treatment 
weights (IPTW). Variables that were included are age2, educational attainment, biological sex, 
Figure 3.1. Simplified DAG for effect of psychosocial stressors on cognitive 
decline and onset of dementia 
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and race and ethnicity. As age is a critical component of these analyses, several functional forms 
of age will be examined, including both linear and quadratic forms of age. The final analysis 
models will be weighted with both IPTW and censoring weights (see below). 
Statistical models: In order to assess the association between the exposure and cognitive 
decline, we used linear mixed-effects models with repeated measures and a random intercept and 
slope to estimate the relationship between amount of psychosocial stress experienced and 
cognitive decline (Model 3.1). This method will account for the repeated outcome measurements 
for each participant and allow us to control for confounding and the effects of time.194 Using 
these models, we will estimate the predicted cognitive trajectories given different profiles of 
psychosocial stress experienced across the lifecourse. 
Model 3.1: $%&'()(*+	,$%-+./ = 	 ["2 + "45&+./ + "6+78%,9-+/ +	":;5&+./ ∗ +78%,9-+/=] +
[92/ + 9./;5&+./= + -./], 
where 
 i denotes a time point within a person 
    j denotes a person 
    92/ is the random intercept for each participant,  
9./ is the random time slope for each participant, and  
rij denotes within-person residual 
 
To assess the relationship between the exposures and incident dementia, we calculated the 
cumulative incidence functions and 95% confidence intervals for each exposure level using the 
Fine-Gray method for accounting for competing risks. Models were weighted with IP weights to 
account for confounding by relevant covariates and LTFU. The Fine-Gray sub distribution 
hazard of cause j is given by 
Model 3.2:  ?/()) = 	−
C
CD
Elog I1 − K/())LM, 
   where 
    j denotes the event type 
    K/ denotes the cumulative incidence function (1-S(t))  
    t denotes a time point 
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Bias due to censoring: From baseline to 2016, the average annual attrition rate in the HRS data 
was 95.2%. This is very good for a longitudinal cohort study, indicating that bias due to loss-to-
follow-up will be small. However, there still may be some bias introduced, as we cannot assume 
that LTFU is completely at random. Several factors, including age, educational attainment, 
general health, change in cognition between prior two visits, and sex. Consequently, for Aim 1a 
we addressed the issue of missing data by weighting our models with IP of censoring weights. 
These weights were created by modeling the likelihood of being present at a wave, given the 
participant was present at the previous wave, controlling for the relevant factors stated above. 
AIM 1b. Investigate whether educational attainment, a possible marker of cognitive 
reserve, modifies the association between lifetime stressors defined in Aim 1 and cognitive 
decline incidence of dementia. The goal of this aim is to assess the effect measure modification 
(EMM) of the associations tested in aim 1a by educational attainment. In order to investigate 
EMM by educational attainment on the multiplicative scale in the cognitive trajectory analyses, 
we created interaction terms between the exposure variables and educational attainment and 
between educational attainment by time and a three-way interaction between the exposure, 
educational attainment, and time. Then we tested for statistical significance of the interaction 
term and ran stratified analyses to report the unit change in total cognition associated with each 
psychosocial stressor level by levels of educational attainment. For incident dementia, we further 
stratified by the cumulative incidence functions by educational attainment. This aim is limited by 
the sample size of our study. With only 4,780 individuals in our dementia study population, 
divided into multiple strata to assess effect measure modification, the sample sizes within each 
stratum were smaller, decreasing our ability to detect statistical significance. Therefore, we 
considered borderline significance (p < 0.10) an important finding. 
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Model 3.3: $%&'()(*+	,$%-+./ = 	 ["2 + "45&+./ + "6+78%,9-+ +	":;5&+./ ∗ +78%,9-+/= +
"O;5&+./ ∗ P%Q(R(+-/= + "S;5&+./ ∗ +78%,9-+/ ∗ P%Q(R(+-/=] + [92/ + 9./;5&+./= + -./], 
where 
 i denotes a time point within a person 
    j denotes a person 
    92/ is the random intercept for each participant,  
9./ is the random time slope for each participant, and  
rij denotes within-person residual 
AIM 2a. Evaluate the association of cytokines and IgG response to persistent 
infections, as measures of immune function, with cognitive trajectory and incidence of 
dementia in an elderly, Latino population. The goal of this aim is to test whether biomarkers 
of immune function are associated with accelerated cognitive decline and incident dementia. 
Exposure variables: 1) standardized IgG titers to CMV, HSV-1, VZV, H. pylori, and T. gondii, 
2) seropositivity to the same pathogens, and 3) standardized cytokine measurements. Outcome 
variables: Both incident dementia and cognitive decline were explored as outcomes. 
Covariates: To address potential confounding, covariates were assessed a priori via DAG 
analysis and a 
minimally sufficient 
adjustment set was 
selected for inclusion 
in a model to create 
IPTWs. There were 
two possible 
minimally sufficient 
adjustment sets for 
this analysis, but as we do not have data in SALSA regarding the psychosocial stressors of 
participants (beyond that of SES), we used the set that does not require psychosocial stressors. 
Figure 3.2. Simplified DAG for effect of immune function on cognitive decline and 
onset of dementia. 
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Variables that were included are age, educational attainment, biological sex, depression, and 
other comorbidities. The final analysis models were weighted with both confounding weights 
and censoring weights (see below). 
Statistical models: In order to assess the association between the exposure and cognitive 
decline, we used linear mixed-effects models with repeated measures and a random intercept and 
slope to estimate the relationship between biomarkers of immune function (exposure) and 
cognitive trajectories (Model 3.1). This method accounts for the repeated outcome 
measurements for each participant and allows us to control for confounding and the effects of 
time.194 Using these models, we estimated the association between cognitive trajectories and 
different levels of immune biomarkers. To assess the relationship between the exposures and 
incident dementia, we calculated the cumulative incidence functions and 95% confidence 
intervals for each exposure level using the Fine-Gray method for accounting for competing risks 
(Model 3.2). Models were weighted with IP weights to account for confounding by relevant 
covariates and LTFU.  
Bias due to censoring: From baseline to 2008, the average annual attrition rate in the SALSA 
study was 5%. Approximately half of this LTFU was due to death (49.5%) and the other half due 
to dropout. Restricting our analysis to complete cases would result in valid estimates only if this 
attrition occurred completely at random. 195 However, the assumption that missing data due to 
loss to follow up occurred completely at random is rarely met in longitudinal epidemiologic 
studies and therefore likely unrealistic for our study. Several factors, including age, educational 
attainment, general health, change in cognition between prior two visits, and sex may be 
associated with LTFU. Consequently, for Aim 3a addressed the issue of missing data by 
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weighting our models with IP of censoring weights. These weights were created by modeling the 
likelihood of being present at a wave, given the participant was present at the previous wave. 
AIM 2b. Investigate whether salivary cortisol, a key stress hormone interacts with 
the above markers of immune function to alter cognitive trajectory and incidence of 
dementia. The goal of this aim is to assess the interaction between the exposures of aim 3a and 
salivary cortisol (high vs. low). In order to investigate this interaction in the cognitive trajectories 
analysis, we created interaction terms between the immune function exposure variables and 
salivary cortisol, between salivary cortisol and time, and a three-way interaction between the 
exposure, salivary cortisol, and time. See Model 3.3. Then we tested for statistical significance 
of the interaction term and reported unit change in total cognition associated with each 1-unit 
change in standardized IgG response (equivalent to 1 SD) or by seropositivity, according to 
levels of salivary cortisol. We did not investigate this interaction in our incident dementia 
analyses. This aim is limited by the sample size of our study. With only 1,204 individuals in our 
study population, divided into multiple strata to assess cortisol levels, the sample sizes within 
each stratum would be too small to detect meaningful associations. 
AIM 2c. Investigate whether educational attainment, a possible marker of cognitive 
reserve, modifies the association between biomarkers defined in Aim 2a and cognitive 
decline and incidence of dementia. 
The goal of this aim is to assess the effect measure modification (EMM) of the 
associations tested in aim 2a by educational attainment. In order to investigate EMM by 
educational attainment on the multiplicative scale in the cognitive trajectory analyses, we created 
interaction terms between the exposure variables and educational attainment and between 
educational attainment by time and a three-way interaction between the exposure, educational 
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attainment, and time. Then we tested for statistical significance of the interaction term and ran 
stratified analyses to report the unit change in total cognition associated with each unit of 
immune biomarker by levels of educational attainment. We did not investigate this interaction in 




CHAPTER 4: LIFECOURSE EXPERIENCES OF TRAUMATIC EVENTS AND 
COGNITIVE DECLINE & INCIDENT DEMENTIA OVER 10 YEARS IN THE 
HEALTH AND RETIREMENT STUDY 
 
4.1 Introduction 
 The proportion of the U.S. population over 65 years old is growing rapidly,166,167 which 
presents a unique health care challenge for the country. The likelihood of decline of cognitive 
function is increased in elderly populations, leading to substantial amounts of cognitive 
impairment and thus both vascular dementia (VaD) and Alzheimer’s Disease (AD), with an 
estimated 5.2 million people over 65 years in the U.S. suffering from AD as of 2016.1 Those 
suffering from any type of dementia are at an elevated risk of several other negative health 
outcomes due to a diminished ability to care for themselves, contributing significantly to 
healthcare costs.169 Therefore, preventing or postponing the onset of dementia is now an explicit 
research priority for the NIH and the CDC,176 but in order to achieve that goal we must improve 
our understanding of factors contributing to cognitive decline and dementia. There are several 
known risk factors for ADRD, including chronological age, ApoE-e4 allele, sex, and education 
levels.3,10,11 However, the search for novel risk factors and early indicators of cognitive decline 
and ADRD continues, and there is compelling data supporting psychosocial stressors as 
important risk factors. 
The literature on the association between psychosocial stressors generally, and lifetime 
traumatic events specifically, and cognition, cognitive change, and dementia has yet to come to a 
clear, scientific consensus on whether there is an association or causal relationship, and if there 
is, what direction it is in. However, there is evidence that traumas occurring specifically during 
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childhood, influence later-life cognitive function, cognitive decline, and incidence of dementia. 
Furthermore, we know that many mental health conditions, including PTSD, depression, and 
schizophrenia, which may result from such traumatic events, have been associated with cognitive 
impairments. Much of the existing evidence comes from cross-sectional studies in specialized 
populations. For example, a study in older Aboriginal Australians found that a 1-SD increase in 
the childhood trauma questionnaire score was associated with a 66% increase in the likelihood of 
being diagnosed with dementia.14 A small study of 47 healthy adults in Witchita, KS, found that 
emotional abuse specifically was associated with impaired spatial working memory performance 
while physical neglect was associated with impaired spatial working memory and pattern 
recognition memory.15 Another study found that in former Swiss child laborers, PTSD is 
associated with cognitive deficits whether or not the participant reported childhood trauma.16 
However, among Holocaust survivors, those who had spent time in a Nazi concentration camp 
did not have higher odds of having dementia compared to survivors who were never in a 
concentration camp.17 However, as these are specific populations who all have experienced 
greater than average stress in their lives, it is possible that the studies do not have adequate 
unexposed groups for meaningful comparisons. 
More representative analyses have found similarly mixed results. Syal et al. found that 
childhood trauma score was significantly associated with poorer spatial and pattern learning in 
women but better learning in men, and these effects were not tempered by later adult adverse 
experiences.18 In a Taiwanese study, PTSD predicted incident dementia over up to 10 years of 
follow-up, and there was a dose-dependent relationship between the severity of PTSD symptoms 
and risk of dementia.19 However, in the Irish Longitudinal Study on Ageing, Feeney et al. found 
that history of childhood sexual abuse was actually associated with better global cognition, 
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memory, executive function, and processing speed among adults 50 and older.20 Finally, over 8 
years of follow-up in the Nurses Health Study II, researchers found that elevated PTSD 
symptoms were associated with worse psychomotor speed and working memory scores.21 
Perhaps this indicates that among those for whom stressful events were severe enough to cause a 
clinical disorder, there is a higher risk of dementia compared to those who were similarly 
exposed but did not get a disorder. 
There is extensive evidence that there is not a consistent relationship between the degree 
to which brain pathology progresses toward characteristic dementia pathology and the degree to 
which cognitive abilities decline, and this evidence has led to the cognitive reserve hypothesis. 
Educational attainment, one marker of socioeconomic status, reflects different levels of resource 
availability throughout the lifecourse, for example through access to healthcare and knowledge 
of healthy behaviors, and therefore may shape one’s ability to minimize the effects of traumatic 
events on cognitive decline.196 In addition, educational attainment may also reflect one’s level of 
cognitive reserve, and thus resiliency of the human brain against the adverse effects of traumatic 
events.  Cognitive reserve, or the capacity for the brain to cope with damage differentially, is 
thought of in one of two ways: as either a passive process in which there is a threshold past 
which neurodegeneration is expressed clinically, or as an active process in which the brain is 
constantly working to compensate for degeneration. The passive models conceptualize this as 
brain size, number of synapses, etc. (i.e. the “hardware” of the brain) being the “reserve”, and 
there is a “critical threshold” at which functional deficits manifest themselves clinically.13,162 
Thus, theoretically, the more reserve one starts with, the more degradation he/she can sustain 
before reaching clinical impairment. The active models, on the other hand, conceptualize reserve 
as “software” that allows someone to process information and tasks more efficiently, and 
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therefore the same amount of degradation in brain physiology may not manifest in the same 
clinical symptoms.13 This ultimately means that even if two individuals sustain the same amount 
of brain pathology, one with more cognitive reserve (i.e. a larger amount of hardware, or a 
greater ability to recruit brain networks efficiently) will present fewer clinical cognitive deficits 
(or none) because of his/her reserve. In practice, cognitive reserve is often proxied by level of 
educational attainment.197 In theory, educational attainment could operate through both the 
hardware and software mechanisms; higher levels of educational attainment during brain 
development could result in more neurons, synapses, etc. for the remainder of the lifecourse, 
while higher levels of educational attainment could also provide the skills necessary for a person 
to compensate for physiologic changes through behaviors and executive functioning. There is 
still, however, debate in the literature as to whether educational attainment is protective of 
neurodegeneration or merely compensates for that degeneration.163 Bosma et al. found that 
mentally demanding work was associated with slower cognitive decline and delayed onset of 
dementia in adults.164 However, Zahodne et al., and other studies, have found that higher 
education level does not slow the rate of cognitive decline.165 In a recent study by Bruandet et al., 
greater cognitive reserve as measured by education level was protective against onset of decline 
but was ultimately associated with a higher rate of cognitive decline, among individuals with AD 
who were followed for 3.5 years.12 
Lifecourse theory is particularly relevant to the research area of psychosocial stress and 
cognition as we have seen that the timing of other established dementia risk factors matters to 
how and how much those factors affect cognition and dementia. The adult brain structure is 
primarily determined during childhood,149 and as such, social and environmental exposures 
occurring during this developmentally important period may be especially influential on later life 
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cognitive trajectories and dementia incidence. In fact, many studies have investigated early life 
genetic factors, childhood intellect, early life SES, physical development, and childhood 
adversity and their association with cognition and dementia. A 2015 review by Seifan et al. 
thoroughly summarizes the evidence of early-life social and environmental factors and their 
effect on AD.150 The authors highlight that the evidence of early-life SES’s effect on AD is 
uncertain; there have been studies finding that early-life socioeconomic disadvantage is 
associated with a higher risk of AD, but also there have been as many studies finding no 
association. More recently, Donley et al. found that childhood stress including living in an 
orphanage, experiencing a crisis, and emigrating, among men, was associated with 1.86 times the 
hazard of being diagnosed with dementia over 25 years of follow-up.151 This is important as 
socioeconomic disadvantage is considered a psychosocial stressor and would likely activate the 
same pathways as the other stressors discussed in this dissertation. Additionally, the effect of 
early-life stress on childhood cognitive function is well established, finding that early-life 
disadvantage and traumatic experiences are associated with diminished cognitive function later 
in childhood.152 However, there is limited research into the effects of these early life experiences 
on cognitive decline and dementia incidence in old age. One study found that maternal death in 
childhood was associated with two times the likelihood of AD in late life,153 and another found 
differential effects of early-life adversity on cognitive decline by race.154  
As demonstrated above, research has focused on childhood as a particularly sensitive 
period, though no study has yet to do a full population-representative longitudinal study on the 
associations between childhood traumatic experiences and cognitive decline and dementia. 
Furthermore, no study has yet to look at whether there are other sensitive periods across the 
lifecourse, apart from childhood, during which exposure disproportionately affects the outcome 
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of interest, distinguishing between early adulthood, mid-life, and late-life in their exposure 
assessment for analysis. Prior studies focused on adult exposures often only investigate 
psychosocial stressors experienced recently, i.e. within the past few weeks or years, rather than 
across the entire lifecourse. Therefore, this study aims to a) estimate the effects of lifetime 
traumatic events (e.g. death of a child) on cognitive trajectory and incidence of dementia over 10 
years of follow-up and b) investigate whether educational attainment, a possible marker of 
cognitive reserve, modifies the association between lifetime stressors defined in part a and 
cognitive decline and incidence of dementia. 
4.2 Methods 
Study Population 
Data for this study come from the Health and Retirement Study (HRS), the largest on-
going nationally representative longitudinal survey of older adults in the U.S., conducted at the 
University of Michigan. HRS began in 1992 and included over 22,000 adults over the age of 50 
years at baseline. Follow-up occurred, and continues to occur, every two years. HRS survey 
design and methods have been described previously.180,181,198 This analysis uses demographic, 
and cognitive data from the 2006 through 2016 waves, with psychosocial data from the 2006 and 
2008 waves’ Psychosocial and Lifestyle Questionnaire. The Psychosocial and Lifestyle 
Questionnaire, which collected data on lifestyle and stress, quality of social ties, personality, 
work-related believes, subjective wellbeing, and self-related beliefs is a self-administered 
questionnaire that was piloted in 2004 and fully implemented in 2006, 2008, and 2010. A 
random 50% of the core panel participants who were chosen to receive the face-to-face interview 
in 2006 were given the Psychosocial and Lifestyle Questionnaire, with the other 50% receiving 
the questionnaire in 2008. Questionnaires were left with participants at the end of their face-to-
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face interview, who completed and returned the questionnaire to the study team via mail. Of the 
9,950 participants who completed either the 2006 or 2008 Psychosocial and Lifestyle 
Questionnaire, our cognitive trajectories analysis included 7,785 individuals who were at least 65 
years old at baseline, had a least two cognitive data points, and had full covariate data. Our 
incident dementia analysis was further restricted to 4,780 individuals with no baseline dementia 
and data available on dementia from the Gianattasio algorithm. Figures A1.1 and 1.2 depict the 
sample derivation. 
Measurements 
Lifetime Traumatic Events. Participants were asked a checklist 7 items which were 
developed for an ongoing study of the health consequences of trauma in older adults from several 
sources.189 The following questions were asked after the prompt “For each of the following events, 
please indicate whether the event occurred at any point in your life. If the event did happen, please 
indicate the year in which it happened most recently.” 1) Has a child of yours ever died? 2) Have 
you ever been in a major fire, flood, earthquake, or other natural disaster? 3) Have you ever fired 
a weapon in combat or been fired upon in combat? 4) Has your spouse, partner, or child ever been 
addicted to drugs or alcohol? 5) Were you the victim of a serious physical attack or assault in your 
life? 6) Did you ever have a life-threatening illness or accident? 7) Did your spouse or a child of 
yours ever have a life-threatening illness. We manually added an eighth component to this 
measure, the death of a spouse, by counting those whose marital status is ‘widowed’ as an 
affirmative response to an eighth question. A cumulative measure of lifetime trauma was be 
created by summing all of the affirmative responses occurring across the lifecourse. If participants 
answered yes to any of the stressful event questions, they were then asked “In what year did this 
event occur?” This information will allow us to create life period-specific measures of trauma, as 
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well. Lifetime Traumas before the age of 18. Participants were asked the following questions, from 
the same source as the Lifetime Traumas checklist, with the prompt of “For the next set of events, 
please think about your childhood growing up, before you were 18 years old.” 1) Before you were 
18 years old, were you ever in trouble with the police? And 2) Before you were 18 years old, did 
either of your parents drink or use drugs so often that it caused problems in the family? 4) Before 
you were 18 years old, were you ever physically abused by either of your parents. A measure of 
childhood trauma will be created by summing the affirmative responses. 
Using the questions described above, we created a) an overall continuous measure of 
traumatic events experienced across the lifecourse and b) a life period-specific continuous measure 
of traumatic events experience. We combined the scores from each set of questions for the overall. 
For the life period-specific measure, we created variables for childhood (ages 0 – 17), early 
adulthood (ages 18 – 34), mid-life (ages 35 – 64), and late-life (ages 65 and up).  
Global Cognition. In HRS, global cognition is a summary variable based on several 
cognitive tests including word recall and mental status items. Questions included in this score 
were asked over telephone by interviewers as part of Telephone Interview for Cognitive Status 
(HRS-TICS) and were answered by the study participant. This variable has a possible range of 0-
35, and includes immediate recall (0-10), delayed recall (0-10), serial 7s (0-5), backwards count 
from 20 (0-2) + object naming (scissors & cactus; 0-2) + President naming (0-1) + Vice 
President naming (0-1) + date naming (month, day, year, day of week; 0-4) encompassing 
cognitive domains of verbal memory, orientation, and executive functioning and attention. The 
HRS-TICS cognitive score will be treated as a continuous measure in analyses. 
Dementia. In HRS, there is no formal clinician-adjudicated diagnosis of dementia or 
specific subtypes of dementia. Therefore, we used an approach previously described first by Hurd 
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et al.183 and subsequently modified by Gianattasio et al.184 which uses existing data collected from 
each wave to categorize participants as having dementia or not. The Hurd et al. paper takes the 
biannually collected cognition data (HRS-TICS) and combines that with data on participants’ 
functional limitations. The HRS-TICS score, described above, will be incorporated. Data on six 
activities of daily living (ADLs), including eating, transferring, toileting, dressing, bathing, and 
walking across a room, and five instrumental activities of daily living (preparing meals, grocery 
shopping, making telephone calls, taking medications, and managing money) are also collected in 
HRS and used in this paper.185 Hurd et al. further used age, educational level, sex, and change in 
ADLs, IADLs, and HRS-TICS in a model to predict dementia. This method also allows us to 
continue using data on those participants who have transferred to proxy interviews due to inability 
to complete the study interviews. In these cases of a proxy interview, the Informant Questionnaire 
on Cognitive Decline in the Elderly (IQCODE),186,187 a validated instrument of 16 questions about 
memory and functional ability of the participant, responses will be incorporated. The Gianattasio 
article defined race and ethnicity – specific cutpoints that improved the sensitivity and specificity 
of the measure within these groups. We took this tool one step further and only define someone 
has having incident dementia if they remain below this threshold for the remainder of their follow-
up time in the study. If someone goes back and forth over the threshold over time, this likely is not 
a case of dementia but rather of low cognition.  
Covariates. Sociodemographic characteristics including educational attainment, sex, age, 
existing comorbidities, and race/ethnicity were collected in the 2006 or 2008 core interview, 
depending on the participant’s respective baseline. These data are self-reported during interviews 
conducted by trained study staff, either in the participant’s home. Educational attainment was 
categorized as less than a high school diploma, high school diploma, some college, or a college 
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diploma and higher. Race/ethnicity was categorized as non-Hispanic White, non-Hispanic Black, 
Hispanic, or other, and biological sex was self-reported as either male or female.   
Statistical Analysis 
All statistical analyses were conducted in SAS 9.4 (SAS Institute, Inc., Cary, North 
Carolina) and figures were created in R using the ggplot2 package. Descriptive statistics were 
used to characterize the study population. In order to estimate the relationship between lifetime 
traumatic events and cognitive level and decline, we used linear mixed effects models with a 
random slope and intercept. To assess the relationship between the exposures and incident 
dementia, we used use stratified cumulative incidence functions with death treated as a 
competing event. Inverse probability weights were used to account for censoring (variables 
included: exposure, educational attainment, age, age2, baseline comorbidities, and change in 
cognition between two prior waves) and confounding (variables included: baseline age2, 
educational attainment, race/ethnicity, and biological sex). Additionally, for lifecourse period-
specific exposures, indicators (yes/no) of events in other lifecourse periods were included in 
confounding weights. This minimally sufficient adjustment set was determined a priori by DAG 
analysis. We further investigated potential effect measure modification by educational attainment 
by running stratified models for each level of educational attainment. Due to the sample size and 
limited power to detect interaction, we will consider P < 0.10 statistically significant for 
interactions. In order to further unravel the relationships and to check the built-in assumption in a 
summary score that each event matters the same amount to health, we completed a sensitivity 
analysis to investigate each individual traumatic event and its association with cognitive 





The 7,785 adults who met eligibility criteria for the cognitive trajectories analysis were 
59% female and 74 years old at baseline, on average, with an age range of 65 to 104 years old. 
One quarter of the study population reported experiencing three or more traumatic events in their 
lifetime, while 22.4% reported never experiencing a traumatic event. Thirty-eight and a half 
percent received a high school diploma while 39.7% attended some college or higher educational 
attainment. Seventy-nine percent of the eligible HRS population identified as non-Hispanic 
White, while 12.2% identified as non-Hispanic Black and 6.9% as Hispanic, and these 
proportions were relatively similar when stratified by number of lifetime traumatic events 
experienced. Mean baseline number of comorbidities was 2.2 (SD=1.4), and the average number 
of comorbidities per participant was higher with each consecutive category of number of 
traumatic events experienced. The mean baseline HRS-TICS score was 22.1 (SD=4.6) overall, 
and it did not differ by number of traumatic life events experienced. The 4,780 adults who met 
eligibility criteria for the incident dementia analysis were slightly older with a mean age of 77 
(range 67 to 99) years and were 59.4% female. A slightly higher proportion identified as non-
Hispanic White (83.2%), while the distribution of educational attainment, the mean baseline 
HRS-TICS score, and the number of lifetime traumatic events reported were roughly equivalent 
to the cognitive decline study population. The complete demographic and social characteristics 
of the study populations for the cognitive decline analyses and incident dementia analyses are 
shown in Table 4.1 and Table 4.2, respectively. Tables A1.1 and A1.2 show the baseline 














 N % N % N % N % N % 
Age, Mean (range) 74 (65, 104) 73 (65, 94) 74 (65, 99) 74 (65, 96) 74 (65, 104) 
           
Sex (N, % Female) 4578 (58.8) 935 (53.7) 1331 (59.3) 1123 (60.8) 1189 (60.9) 
           
Education           
Less than High School 1702 (21.9) 365 (21.0) 501 (22.3) 423 (22.9) 413 (21.1) 
High School Diploma 2998 (38.5) 706 (40.6) 887 (39.5) 689 (37.3) 716 (36.6) 
Some College 1584 (20.4) 320 (18.4) 403 (18.0) 385 (20.8) 476 (24.4) 
College Diploma + 1501 (19.3) 349 (20.1) 453 (20.2) 350 (19.0) 349 (17.9) 
           
Race/Ethnicity           
Non-Hispanic White 6182 (79.4) 1350 (77.6) 1783 (79.5) 1492 (80.8) 1557 (79.7) 
Non-Hispanic Black 948 (12.2) 208 (12.0) 262 (11.7) 233 (12.6) 245 (12.5) 
Hispanic 535 (6.9) 155 (8.9) 156 (7.0) 102 (5.5) 122 (6.2) 
Other 120 (1.5) 27 (1.6) 43 (1.9) 20 (1.1) 30 (1.5) 
           
TICS Score, Mean (SD) 22 (4.6) 22 (4.5) 22 (4.8) 22 (4.5) 22 (4.6) 
           
Lifetime Traumatic Events           
0 Events 1740 (22.4)         
1 Event 2244 (28.8)         
2 Events 1847 (23.7)         
3+ Events 1954 (25.1)         
           
Lfetime Traumatic Events (N, % 1 or more)         
Early Life 1478 (19.0) 0 (0.0) 225 (10.0) 394 (21.3) 859 (44.0) 
Young Adulthood 1397 (17.9) 0 (0.0) 289 (12.9) 396 (21.4) 712 (36.4) 




Late Life 2845 (36.5) 0 (0.0) 774 (34.5) 924 (50.0) 1147 (58.7) 
           
















 N % N % N % N % N % 
Age, Mean (SD) 77 (67, 99) 76 (67,  94) 77 (67, 99) 77 (68, 96) 78 (67, 98) 
           
Sex (N, % Female) 2838 (59.4) 533 (53.4) 856 (60.7) 733 (62.0) 716 (60.3) 
           
Education           
Less than High School 1018 (21.3) 208 (20.8) 307 (21.8) 267 (22.6) 236 (19.9) 
High School Diploma 1861 (38.9) 408 (40.8) 562 (39.8) 450 (38.1) 441 (37.1) 
Some College 959 (20.1) 183 (18.3) 252 (17.9) 239 (20.2) 285 (24.0) 
College Diploma + 942 (19.7) 200 (20.0) 290 (20.6) 226 (19.1) 226 (19.0) 
           
Race/Ethnicity           
Non-Hispanic White 3979 (83.2) 818 (81.9) 1187 (84.1) 997 (84.4) 977 (82.2) 
Non-Hispanic Black 518 (10.8) 103 (10.3) 141 (10.0) 125 (10.6) 149 (12.5) 
Hispanic 283 (5.9) 78 (7.8) 83 (5.9) 60 (5.1) 62 (5.2) 
*No Other in dementia set           
           
TICS Score, Mean (SD) 22 (4.3) 22 (4.2) 22 (4.4) 22 (4.3) 22 (4.3) 
           
Lifetime Traumatic Events           
0 Events 999 (20.9)         
1 Event 1411 (29.5)         
2 Events 1182 (24.7)         
3+ Events 1188 (24.9)         
           
Lifetime Traumatic Events (N, % 1 or more)         
Early Life 811 (17.0) 0 (0.0) 114 (8.1) 229 (19.4) 468 (39.4) 
Young Adulthood 871 (18.2) 0 (0.0) 186 (13.2) 259 (21.9) 426 (35.9) 
Mid Life 1582 (33.1) 0 (0.0) 389 (27.6) 485 (41.0) 708 (59.6) 




           
Incident dementia (not baseline) 1416 (29.6) 256 (25.6) 443 (31.4) 344 (29.1) 373 (31.4) 
           
Comorbidities, Mean (SD) 2.2 (1.3) 1.9 (1.2) 2.1 (1.3) 2.3 (1.3) 2.5 (1.4) 
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Overall Cross-sectional Cognitive Function 
 Table 4.3 shows the association between the total number of traumatic events 
experienced across the lifecourse (in line with the accumulation of risks model) and population 
mean cognitive level, before and after weighting. In IP-weighted models, we found that those 
experiencing any number of traumatic events (i.e. 1, 2, or 3 or more) had significantly higher 
mean HRS-TICS scores compared to those who experienced no traumatic live events during 
their lifetime. Those who experienced 2 or 3+ events had HRS-TICS scores 0.60 (95% CI: 0.35, 
0.85) and 0.56 (95% CI: 0.31, 0.81) points higher than those who experienced no events. 
However, Table 4.4 shows the association between traumatic events experienced during a 
specific life period and cognitive function. While there is no significant association between 
traumatic events experienced during mid-life and HRS-TICS, there were statistically significant 
associations for each other life period examined. Compared to those who experienced no 
traumatic events during early life, and controlling for traumatic events experienced during other 
life periods in IP weights, those who experienced one or more traumatic events before the age of 
19 had a mean HRS-TICS score 0.40 (95%CI: 0.17, 0.63) points higher and those who 
experienced one or more events during young adulthood (ages 19-34) had a mean HRS-TICS 
score 0.35 (95%CI: 0.12, 0.58) points higher. The association was largest among those who 
experienced one or more traumatic events at the age of 65 or above; these participants had a 
mean HRS-TICS score 1.11 (95%CI: 0.84, 1.38) points higher than those who experienced no 




Table 4.3. Fixed Effects Estimates from Linear Mixed Effects Models of Lifetime 
Traumatic Events and Cognitive Decline in the HRS, n=7,785 
  Overall (Entire Lifecourse) 
  Crude Models  
IP Weighted Models - 
Accumulation of Risk 
Variable  Estimate 95% CI  Estimate 95% CI 
Intercept  21.63 21.46, 21.79  21.56 21.38, 21.73 
Traumatic Events         
1  0.37 0.15, 0.59  0.33 0.09, 0.57 
2  0.69 0.45, 0.92  0.60 0.35, 0.85 
3  0.69 0.45, 0.92  0.56 0.31, 0.81 
0  ref.    ref.   
Age  -0.25 -0.27, -0.24  -0.31 -0.32, -0.29 
Age2  -0.01 -0.01, -0.01     
Traumatic Events * Age       
1  -0.02 -0.04, 0.01  -0.05 -0.07, -0.02 
2  0.00 -0.02, 0.03  -0.03 -0.06, 0.00 
3  0.01 -0.02, 0.03  -0.04 -0.06, -0.01 




Table 4.4. Fixed Effects Estimates from Linear Mixed Effects Models of Lifecourse Period Traumatic Events and Cognitive Decline in 
the HRS, n=7,785 
 Early Life Young Adulthood 
 Crude Models IP Weighted Models  Crude Models IP Weighted Models  
Variable Estimate 95% CI Estimate 95% CI Estimate 95% CI Estimate 95% CI 
Intercept 21.95 21.85, 22.04 21.84 21.75, 21.94 21.98 21.89, 22.08 21.85 21.75, 21.95 
Traumatic Events             
1 0.55 0.34, 0.76 0.40 0.17, 0.63 0.35 0.14, 0.57 0.35 0.12, 0.58 
0 ref.   ref.   ref.   ref.   
Age -0.25 -0.27, -0.24 -0.34 -0.35, -0.33 -0.26 -0.27, -0.25 -0.34 -0.35, -0.33 
Age2 -0.01 -0.01, -0.01    -0.01 -0.01, -0.01    
Traumatic Events * Age            
1 0.00 -0.02, 0.02 0.03 0.00, 0.05 0.02 0.00, 0.04 0.01 -0.02, 0.03 
0 ref.     ref.     ref.     ref.     
             
 Mid Life Late Life 
 Crude Models IP Weighted Models  Crude Models IP Weighted Models  
Variable Estimate 95% CI Estimate 95% CI Estimate 95% CI Estimate 95% CI 
Intercept 21.94 21.83, 22.05 21.88 21.76, 21.99 21.95 21.84, 22.05 21.76 21.65, 21.86 
Traumatic Events             
1 0.25 0.08, 0.42 0.13 -0.05, 0.31 0.33 0.14, 0.53 0.82 0.62, 1.03 
0 ref.   ref.   ref.   ref.   
Age -0.25 -0.26, -0.24 -0.34 -0.35, -0.33 -0.26 -0.28, -0.25 -0.30 -0.32, -0.29 
Age2 -0.01 -0.01, -0.01    -0.01 -0.01, -0.01    
Traumatic Events * Age            
1 -0.01 -0.03, 0.01 0.02 0.00, 0.04 0.01 -0.01, 0.04 -0.10 -0.12, -0.08 




Lifetime Traumatic Events and Cognitive Decline 
 Tables 4.3 and 4.4 and Figure 4.1 also show the association between the total number of 
traumatic events experienced across the lifecourse and cognitive decline over the course of 
follow-up. Experiencing any events over the entire lifecourse was statistically associated with 
rate of change in HRS-TICS score in our study population. For each year of age, experiencing 
one or more traumatic events was associated with 0.05 (95%CI: 0.02, 0.07) fewer HRS-TICS 
points, indicating an accelerated rate of cognitive decline compared to those who did not 
experience any traumatic events during their life. Table 4.4 demonstrates that this association is 
largely driven by those experiencing event in late life. For each year of age, experiencing one or 
more traumatic events after age 64 was associated with 0.10 (95%CI: 0.08, 0.12) fewer HRS-
TICS points indicating an accelerated rate of cognitive decline compared to those who did not 
experience any traumatic events in late life. However, experiencing traumatic events during other 






Figure 4.1. Fixed Effects Associations Between Lifecourse Experiences of Traumatic Events 
and Mean Population Cognitive Function and Cognitive Decline. This figure shows the fixed 
effects beta estimates and 95% confidence intervals for the exposure (main effect) and 
exposure*age (slope) terms from linear mixed effects models assessing the association between 
lifecourse traumatic events (accumulation and sensitive period models, specified on the y-axis) 
and cognitive function (HRS-TICS, specified on the x-axis; higher score is equivalent to higher 
cognitive function). 
 
Lifetime Traumatic Events and Incident Dementia 
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Figure 4.2 depicts the IP-weighted cumulative incidence of dementia, stratified by 
experience of traumatic events. Panel a, demonstrates no meaningful difference in risk of 
dementia by the number of events experienced across the lifecourse. Panels b - e depict the 
cumulative incidence functions for each life period, showing no largely difference in the 
incidence of dementia by experiencing a traumatic event during any particular life period. 
However, among those surviving to age 90, there is a slightly higher risk of dementia among 





Figure 4.2. Cumulative Incidence of Dementia by Lifecourse Traumatic Events. This figure depicts the cumulative incidence of 
dementia, IP-weighted to account for censoring and confounding, for each form of the exposure. Panel (a) depicts the association with 
cumulative lifecourse traumatic events (0, 1, 2, or 3+ events); panel (b) shows incidence stratified by early-life events; panel (c) shows 
incidence stratified by young-adulthood events; panel (d) shows incidence stratified by mid-life events; and panel (e) shows incidence 






Effect Measure Modification by Educational Attainment 
 We found statistically significant effect measure modification by educational attainment 
between the accumulation of lifetime traumatic events score and each life period-specific 
indicator of traumatic experiences and HRS-TICS, as well as with accumulation score and late 
life events and rate of HRS-TICS decline, results presented in Tables 4.5 and 4.6. With the 
accumulation of risk model, we see that the strength of the association is larger and statistically 
significant among those with a high school diploma or less education. When investigating 
modification of lifecourse specific periods of event, we see similarly that the association is 
stronger the less educational attainment one has, and is often only statistically significant in the 
lower education strata. For example, those who experienced an event in early life and did not 
complete high school had an HRS-TICS score 0.60 (95%CI: 0.04, 1.15) points higher than those 
who did not experience any events, while those with higher educational attainment did not see a 
statistically significant association with experiencing an early life event and cognition. A similar 
pattern is borne out with respect to the association with the rate of cognitive decline, where the 
slope of cognition over time is larger among those with less educational attainment. This is only 
seen when looking at late life events, as expected based on the non-stratified models. However, 
the associations are strongest among those with a high school diploma, not less than that, when 





Table 4.5. Education-stratified Fixed Effects Estimates from Linear Mixed Effects Models of Lifetime Traumatic Events (Accumulation 
of Risk) and Cognitive Decline in the HRS, n=7,785 
 < High School High School Some College College +  
Variable Estimate 95% CI Estimate 95% CI Estimate 95% CI Estimate 95% CI p-value 
Intercept 17.90 17.51, 18.29 21.54 21.30, 21.78 22.93 22.60, 23.26 24.01 23.73, 24.29  
Lifetime Traumatic 
Events            <0.0001 
1 0.00 -0.53, 0.54 0.54 0.21, 0.87 0.10 -0.36, 0.56 0.44 0.05, 0.83  
2 0.94 0.37, 1.51 0.73 0.38, 1.09 0.11 -0.35, 0.58 0.26 -0.15, 0.67  
3 0.80 0.22, 1.38 0.45 0.10, 0.80 0.29 -0.16, 0.73 0.46 0.04, 0.88  
0 ref. . . ref. . . ref. . . ref. . .  
Age -0.29 -0.33, -0.25 -0.26 -0.29, -0.23 -0.31 -0.36, -0.27 -0.32 -0.36, -0.28 0.8121 
Traumatic Events * Age            0.0193 
1 -0.03 -0.09, 0.02 -0.08 -0.12, -0.04 -0.03 -0.08, 0.03 0.02 -0.03, 0.07  
2 -0.01 -0.07, 0.04 -0.06 -0.11, -0.02 0.00 -0.06, 0.06 0.03 -0.03, 0.08  
3 -0.10 -0.16, -0.04 -0.03 -0.08, 0.01 0.00 -0.05, 0.06 0.00 -0.05, 0.05  






Table 4.6. Education-stratified Fixed Effects Estimates from Linear Mixed Effects Models of Lifecourse Period Traumatic Events 
(Sensitive Period) and Cognitive Decline in the HRS, n=7,785 
 < High School High School Some College College + 
p-value Variable Estimate 95% CI Estimate 95% CI Estimate 95% CI Estimate 95% CI 
Intercept 18.20 17.98, 18.41 21.91 21.77, 22.04 23.03 22.86, 23.21 24.29 24.13, 24.44  
Early Life Events             <.0001 
1 0.60 0.04, 1.15 0.28 -0.04, 0.59 0.21 -0.19, 0.61 0.07 -0.31, 0.45  
0 ref.   ref.   ref.   ref.    
Age -0.32 -0.34, -0.30 -0.31 -0.33, -0.30 -0.33 -0.35, -0.30 -0.31 -0.33, -0.29 0.4240 
Early Life TE * Age             0.2981 
1 -0.02 -0.08, 0.04 0.05 0.01, 0.09 0.02 -0.03, 0.07 0.03 -0.02, 0.08  
0 ref.   ref.   ref.   ref.    
              
Intercept 18.16 17.95, 18.38 21.92 21.79, 22.05 23.11 22.93, 23.29 24.29 24.13, 24.44  
Young Life Events             <.0001 
1 0.83 0.28, 1.39 0.16 -0.17, 0.49 -0.20 -0.60, 0.19 0.06 -0.31, 0.43  
0 ref.   ref.   ref.   ref.    
Age -0.33 -0.35, -0.30 -0.31 -0.33, -0.29 -0.32 -0.35, -0.30 -0.31 -0.33, -0.29 0.8532 
Young Life TE * Age            0.9081 
1 0.00 -0.06, 0.06 0.01 -0.03, 0.05 0.01 -0.04, 0.06 -0.01 -0.05, 0.04  
0 ref.   ref.   ref.   ref.    
              
Intercept 18.33 18.08, 18.59 21.96 21.80, 22.12 23.08 22.87, 23.30 24.19 24.00, 24.37  
Mid Life Events             <.0001 
1 -0.14 -0.55, 0.27 0.02 -0.23, 0.27 -0.02 -0.34, 0.30 0.36 0.06, 0.66  
0 ref.   ref.   ref.   ref.    
Age -0.33 -0.35, -0.30 -0.31 -0.33, -0.29 -0.33 -0.36, -0.31 -0.31 -0.34, -0.29 0.8927 
Mid Life TE * Age             0.6591 
1 0.01 -0.04, 0.05 0.01 -0.03, 0.04 0.03 -0.01, 0.07 0.02 -0.02, 0.06  
0 ref.   ref.   ref.   ref.    
              
Intercept 17.99 17.74, 18.24 21.73 21.58, 21.87 22.88 22.69, 23.07 24.21 24.04, 24.38  




1 1.07 0.61, 1.53 1.09 0.81, 1.37 0.80 0.42, 1.18 0.52 0.17, 0.87  
0 ref.   ref.   ref.   ref.    
Age -0.30 -0.32, -0.27 -0.28 -0.30, -0.26 -0.32 -0.34, -0.29 -0.30 -0.32, -0.27 0.8194 
Late Life TE * Age             0.0573 
1 -0.10 -0.14, -0.06 -0.12 -0.15, -0.08 -0.04 -0.09, 0.00 -0.06 -0.10, -0.01  







Figure 4.3. Education-stratified Fixed Effects Associations Between Lifecourse Experiences of Traumatic Events and Mean 
Population Cognitive Function and Cognitive Decline. This figure shows the fixed effects beta estimates and 95% confidence 
intervals for the exposure (main effect) and exposure*age (slope) terms from linear mixed effects models assessing the association 
between lifecourse traumatic events (accumulation and sensitive period models, specified on the y-axis) and cognitive function (HRS-




 Figure 4.4 shows the cumulative incidence of dementia in this population, paneled by 
educational attainment. Among those who did not complete high school, experiencing no 
traumatic events across the lifecourse was associated with a higher incidence of dementia 
compared to those who experienced any number of events (panel a). Furthermore, we found 
significant effect measure modification by educational attainment when investigating lifecourse 
period-specific traumatic events. However, there was no consistent pattern of this modification. 
When experiencing an event in childhood, those with a college degree or more had a 
significantly higher incidence of dementia compared to (panel b). We see modification for mid 
and late-life events as well. There is a statistically significant association with incident dementia 
among those with a college degree or more, but those who experienced no traumatic events 






Figure 4.4. Cumulative Incidence of Dementia by Lifecourse Traumatic Events and Educational Attainment. This figure 
depicts the cumulative incidence of dementia, IP-weighted to account for censoring and confounding, for each form of the exposure. 
Panel (a) depicts the association with cumulative lifecourse traumatic events (0, 1, 2, or 3+ events); panel (b) shows incidence 
stratified by early-life events; panel (c) shows incidence stratified by young-adulthood events; panel (d) shows incidence stratified by 






Sensitivity Analysis of Individual Traumatic Events 
 Analysis of each individual traumatic event and its association with cognition and rate of 
decline indicate that type of event does matter. Those who experienced the loss of a child or were 
the victim of a serious physical attack during their life had significantly lower HRS-TICS scores 
than those who did not experience these types of events (-0.89, 95%CI: -1.14, -0.63; -0.55, 
95%CI: -0.96, -0.14 respectively). On the other hand, those who had ever been in a major natural 
disaster or whose spouse, child, or other close relation had ever had a life-threatening illness or 
accident had higher HRS-TICS scores than those who had not experienced that (0.54, 95%CI: 
0.29, 0.79; 0.72, 95%CI: 0.51, 0.94 respectively). The association of traumatic events with rate 
of cognitive decline appears to be driven primarily by experiencing the death of a spouse, which 
for each decade of age was associated with 0.1 more HRS-TICS points of decline compared to 
those who had not experienced the death of a spouse. These associations are depicted in Figure 
4.5. This pattern was not borne out with dementia incidence, however, with which we found an 
association only when comparing those whose parent(s) drank or used drugs so often that it 




Figure 4.5. Fixed Effects Associations Between Individual Traumatic Events and Mean 
Population Cognitive Function and Cognitive Decline. This figure shows the fixed effects 
beta estimates and 95% confidence intervals for the exposure (main effect) and exposure*age 
(slope) terms from linear mixed effects models assessing the association between each specific 






Figure 4.6. Cumulative Incidence of Dementia by Lifecourse Traumatic Events. This figure depicts the cumulative incidence of 
dementia, IP-weighted to account for censoring and confounding, for each specific traumatic event. Cumulative incidence functions 
were estimated using the Aalen-Johansen estimator. 
 
a) b) c) d)
e) f) g) h)
i) j)
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4.4 Discussion 
We found that overall, lifetime experience of traumatic events was statistically 
significantly associated with a higher level of cognitive function and faster rate of cognitive 
decline but not associated with the incidence of dementia in up to 10 years of a US population-
based survey of adults over the age of 65. When investigating life-period specific occurrence of 
these events, however, we identified interesting trends. The association of was strongest among 
those who experienced traumatic events in late life, and the association with rate of decline 
appeared to be largely driven by events experienced in late life. The observed relationships were 
modified by the educational attainment of participants. The associations were strongest among 
those with the lowest educational attainment (i.e. less than a high school diploma). Interestingly, 
based on our sensitivity analysis, the type of traumatic event is important and determines not 
only the strength but also the direction of the association with cognitive trajectories. Two events, 
the death of a child and being the victim of a serious physical assault, were associated with lower 
cognitive function. On the other hand, being in a major natural disaster or having a close relation 
experience a life-threatening illness or accident were associated with higher cognitive function.  
Prior research has found mixed associations between traumatic events and cognitive 
function and decline. In the Irish Longitudinal Study on Ageing, Feeney et al. found that history 
of childhood sexual abuse was associated with better global cognition, memory, executive 
function, and processing speed among adults 50 and older.20 Grimby and Berg found, over 6 years, 
that cognitive decline was not associated with SLEs except in the case of bereavement, suggesting 
that more traumatic events may be more impactful.39 Finally, Tschanz et al. found that SLE effects 
on cognition over up to 7 years, vary by educational attainment and type of SLE.40 Our results are 
in line with these findings, as we have shown associations with traumatic events and higher 
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cognitive function, though it depends on the event. Several studies have found that an 
accumulation of stressful or traumatic events is associated with specific domains of cognitive 
function or MCI.32,34 However there have been many studies with null findings with regard to 
stressful or negative life events and dementia in a study by Sundstrom et al.,35 with cognitive 
domain performance by Ouanes et al.,36 and with MCI by Pilleron et al.34 
This wide variety of association directions, magnitudes, and significance is in line with the 
results of our study. While we found that, overall, accumulation of traumatic life events was 
associated with better cognition and slightly faster decline, our sensitivity analysis determined that 
the associations vary meaningfully by which specific event a person experienced. Within the 
psychosocial stressor research there is inconsistency in which events are actually measured and 
included in the studies. Despite being referred to similarly as stressful, adverse, or traumatic 
events, for example, the actual events included are not uniform. As we found that the specific event 
matters and can change even the direction of the association, it is not surprising that the literature 
in this area is inconsistent.   
Established pathways through which psychosocial stressors including traumatic events 
may influence cognition include access to care and altered health behaviors. However, these 
pathways do not account for all of the variation in cognitive function, rate of cognitive decline, 
and incidence of dementia. An important biological pathway through which psychosocial 
stressors may ultimately impact cognitive function and lead to dementia is through changes to 
the immune system elicited by chronic stress. Existing literature supports the theories that 
psychosocial stressors chronically activate the innate immune system through stress hormones 
and the hypothalamic-pituitary-adrenal (HPA) axis and this overactivation subsequently affects 
brain physiology. The biological mechanisms at play here are described in detail below. 
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While the evidence that psychosocial stressors impact long-term health has existed for 
decades, only more recently have the biological mechanisms through which these stressors get 
under the skin and affect physiologic systems been elucidated. Research has shown a plausible 
mechanism by which psychosocial stressors elicit a neuroendocrine response to stress, operating 
through an activation of the hypothalamic-pituitary-adrenal (HPA) axis and the sympathetic 
nervous system (SNS).43 These associations are believed to operate through stress-induced 
neuroendocrine activation, leading to a release of pituitary and adrenal stress hormones including 
ACTH, catecholamines, prolactin, and cortisol.44 These hormones then alter immune function by 
either binding directly to immune cells, including T and B cells, mast cells, dendritic cells, 
macrophages, and natural killer cells,45 or inducing dysregulation of cytokines, including IFN-γ, 
interleukin (IL)-1, IL-2, IL-6, and TNF.46,47  
A few studies have also investigated the association between trauma and physical measures 
of brain size, such as hippocampal volume and prefrontal cortex (PFC) thickness, precursor 
indications of declining cognitive function. Karstens et al. found that trauma experienced was 
associated with greater PFC thickness, independent of depression, but was not associated with 
hippocampal volume.22 Another study found that childhood trauma was associated with reduced 
hippocampal volume only in males, not in females,23 while a third study specifically looked at 
women diagnosed with PTSD, dissociative amnesia (DA), or dissociative identity disorder (DID) 
from childhood abuse and found that PTSD was associated with reduced amygdala and 
hippocampal volume as well as impaired cognition, compared to healthy controls.24 
 Our study has several strengths, including the use of a large, U.S.-population based 
longitudinal cohort study with over 7,500 eligible participants. This study had up to 10 years of 
follow-up cognitive data, with an average of six years for the entire study. Furthermore, the 
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Lifestyle & Psychosocial Questionnaire provided details on 10 traumatic events and when in the 
lifecourse they occurred. It is rare to have such important information available on psychosocial 
stressors. However, our study also has several limitations. We expect measurement error in the 
cognitive measures. The HRS-TICS is a limited measure of global cognition, and the algorithm 
used to diagnosis dementia has limited sensitivity and specificity. There is also the potential for 
bias in our results due to unmeasured confounding. One of particular concern is the potential for 
confounding by indication; that is, those with a better memory (resulting in a higher global 
cognition score) would likely more accurately report their exposure, as it is measured by self-
report. In this case, those with better cognitive scores would be more likely to accurately report 
being exposed, while those with lower cognitive scores would not report an exposure. With the 
particular instances of traumatic events of interest in this study, the likelihood of not remembering 
is small, but this may be a larger issue with other psychosocial stressors. 
There are clear limitations to using educational attainment as a proxy measure for 
cognitive reserve, particularly in research about psychosocial stressors. Educational attainment, a 
common marker of socioeconomic status, is in itself, a marker of psychosocial stress. 
Additionally, while these associations between educational attainment and rate of decline have 
been seen, we do not know whether educational attainment is associated with any brain 
pathology or how it is associated processing, therefore our ability to understand how we’re 
investigating the “hardware” and “software” cognitive reserve hypotheses is very limited. This 
will possibly result in bias in study results due to measurement error. Furthermore, educational 
attainment, categorized by degree, will likely have large variation within each category as well as 
between categories.  
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One of the most important limitations of this research is selection bias. The population 
we were able to investigate in this study includes only those individuals who survived to ages 60 
or 65 and were community-dwelling and healthy enough to be enrolled into their respective 
studies. This leaves a large amount of time between exposure and study enrollment, particularly 
for early-life and young-adulthood traumatic events. During the period between exposure and 
study enrollment, there may have been unobserved health impacts on the exposed group. Those 
who were exposed may have been less likely to enroll in the HRS, or they may even have been 
less likely to survive until the age of eligibility. Therefore, those who were most impacted by the 
exposure of interest may not even be included in our study population. 
Cognitive decline is a normal phenomenon: as we age, our reasoning, memory, and 
processing speed begin to decline, and our brains physically change by decreasing grey matter 
volume, forming β-amyloid plaques, and experiencing neuronal cell death.177 However, there is 
significant heterogeneity in the rate at which individuals’ brain function declines and the age at 
which this decline crosses the threshold into clinical cognitive impairment. This paper aims to 
contribute to understanding that heterogeneity. The accumulation of psychosocial stressors is a 
complex issue influenced by sex, race/ethnicity, SES, early-life living conditions, and 
educational attainment. Despite this complexity, because dementia and cognitive impairment are 
major health issues that require high priority for prevention at the individual and community 
level, delving into these relationships is critical, and our study aims to improve recommendations 
for identifying high risk individuals and prevention targets. Current cognitive-decline and 
dementia delay prevention recommendations from the Alzheimer’s Association include lifestyle 
changes such as increasing exercise (both physical and cognitive), eating healthy, getting enough 
sleeping, and quitting smoking.199,200 Current screening for dementia involves primarily relying 
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on a significant other or their primary care physician to identify cognitive deficits before referral 
to a neurologist, psychologist, or geratrician.201 Our study provides information regarding how 
stressors that may be experienced across the life course are associated with cognitive decline and 
onset of dementia.  
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CHAPTER 5: IMMUNE FUNCTION, CORTISOL, AND COGNITIVE DECLINE & 
DEMENTIA IN AN AGING LATINO POPULATION 
 
5.1 Introduction 
 Recent evidence has implicated senescing immune cells, inflammation, and chronic 
infection as risk factors for both cognitive decline and incident dementia.93,94 Cross-sectional as 
well as longitudinal studies have shown that higher levels of CRP, IL-6, TNF-alpha, and other 
cytokines are associated with lower cognitive level,103,104 and higher dementia incidence.104,106 
Furthermore, immune response to infection and inflammation have been implicated in the 
accumulation of amyloid-!, a key pathological feature of Alzheimer’s Disease and related 
dementias (ADRD) and associated with other neurodegenerative processes such as microglial 
senescence.93,124,202 The resulting shifts in the T-cell compartment toward aged T-cell phenotypes 
(i.e. lower CD4+:CD8+ and effector memory:naïve T-cell ratios) may also play a role.203 
However, several studies have reported no significant associations with immune markers and 
cognition, but comparisons are difficult given the various populations, markers and outcomes 
that have been examined across studies.108,112,113,204-206 
The stress-related elevation of cortisol and dysregulated cortisol rhythms has been 
implicated in numerous adverse health outcomes including cardiovascular disease,207 Type 2 
Diabetes,208 and cognitive function and ADRD.209,210 Importantly, cortisol and immune cells are 
biologically connected. Cytokines, cell signaling proteins in the innate immune response, can 
activate the HPA axis, inducing production of cortisol, but cortisol may also affect immune 
pathways by binding to glucocorticoid receptors on innate and adaptive cells.211 Furthermore, 
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chronic inflammation has been shown to induce glucocorticoid resistance.212 Yet, there are few 
studies that have assessed the interactions among cortisol and immune cells, and particularly how 
they may modify cognition in older age. 
This study aimed to examine the association of cytokines and pathogen IgG response 
with cognitive decline and incidence of dementia in an elderly, Latinx population, and 
investigate whether salivary cortisol interacts with these biomarkers to alter cognitive trajectory 
and dementia incidence. We also investigated effect measure modification of the immune – 
cognition relationship by educational attainment. 
5.2 Methods 
Study Population 
 This study uses data from the Sacramento Area Latino Study of Aging (SALSA), a 
prospective, observational community-based cohort study of 1,789 self-designated Latina/Latino 
(designated as Latinx from here on out) adults in the Sacramento Valley, CA area who were aged 
60 years or older at baseline. SALSA survey design and methods have been described 
previously.179 Baseline 2-hour interviews occurred at the participants’ homes during 1998-1999. 
The interview included questions regarding lifestyle factors, depressive symptoms, acculturation, 
and medical diagnoses. Buccal swabs for DNA, blood pressure, and fasting blood samples were 
taken at baseline. Follow-up visits occurred every 12-15 months, with a total of 7 follow-up 
visits over 10 years, during which participants reported health conditions and lifestyle and 
sociodemographic risk factors and completed a cognitive evaluation. Our analysis used existing 
immune function biomarker data collected on a sub-sample of 1,574 participants at baseline. We 
further restricted our analysis to individuals with at least two cognitive data points and complete 
covariate data, for a final sample size of 1,337. 
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Measures 
 Exposures  
  Cytokines  
 Blood samples were collected from participants in their homes by trained phlebotomists 
and transferred on ice to be processed. Serum samples have since been stored continuously 
frozen at -70 ºC, and this storage protocol has been proven to have minimal effects on reliability 
of measurements conducted at later time points, with antibodies to viruses stable over time when 
continuously frozen.190 hs-CRP levels above 40 were excluded from analysis as high levels may 
indicate acute infection. For the purposes of statistical analysis, IL-6, hs-CRP, and TNF-alpha 
and were log transformed then modeled as continuous and dichotomous at the mean. Additional 
details for laboratory testing of cytokines and pathogens are provided in the Supplementary 
Material. 
  Pathogens 
Baseline blood serum samples were analyzed for level of IgG antibodies to the 
cytomegalovirus (CMV), herpes simplex virus (HSV)-1, varicella zoster virus (VZV), 
toxoplasma gondii (T, gondii), and helicobacter pylori (H. pylori) using enzyme-linked 
immunosorbent assays (ELISA). Through a series of incubation and wash steps, the antibodies 
specific to our viruses of interest were linked to antibodies present in our samples and then to a 
secondary reactive antibody. These assays generated values on a continuous scale, reported as 
optical density (OD) units, that correspond to the level of IgG antibodies in the blood. In addition 
to the continuous measurement of IgG response, the laboratory determined whether each sample 
was seropositive or seronegative for each virus based on established cutoffs of IgG response. 
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Each commercial ELISA kit contained controls and internal calibrations. For the purposes of 
analysis, all IgG titer variables were standardized to a mean of 0 and a SD of 1.  
 Salivary Cortisol 
Salivary cortisol was measured from buccal swabs collected as a waking sample at 
baseline. The salivary cortisol testing was collected with Salivettes (Sarstedt, Newton, NC) and 
assayed unextracted with DPC Coat a Count cortisol kits (DPC. Los Angeles, CA). Cortisol was 
log transformed for analysis. 
 Outcomes 
  Global Cognition 
Global cognition was measured at baseline and each follow-up visit using the modified 
Mini-Mental State Examination (3MSE).34 The 3MSE tests a variety of cognitive abilities 
including recall, attention and calculation, registration, and orientation to time and place and is a 
common measure of cognitive ability in our populations. With 30 questions total, each varying in 
score value, the 3MSE has a final score range of 0 – 100, a sum of each individual question’s 
score.34,61 Due to the negatively skewed distribution, we modeled this outcome as the log of the 
errors on the test (i.e. log(101-3MSE)).  
  Clinician Adjudicated Dementia Diagnosis 
Clinical diagnosis of dementia was a multistage process beginning if participants scored 
below the 20th percentile on the 3MSE or their score declined by >8 points since the previous 
exam. These participants were referred to take a neuropsychological test battery and were further 
referred to neuropsychologists if they received scores below the specified cutoffs. A 
neuropsychologist or neurologist then diagnosed type of dementia based on the National Institute 
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of Neurological and Communicative Disorders and Stroke and the Alzheimer’s Disease and 
Related Disorders Association criteria.188 
 Covariates 
 Sociodemographic data including years of educational attainment, sex (male/female), age 
(grand mean centered at baseline age, quadratic), self-reported health, and depressive symptoms 
(CES-D) were self-reported at baseline, and self-reported health and depressive symptoms were 
subsequently collected at each follow-up visit. Educational attainment was reported as the 
number of years attended and categorized as less than 8th grade, 8th grade diploma, or high school 
diploma and above for analysis, thus basing the measure on the highest degree obtained. Self-
reported health was reported on a 5-point Likert scale from excellent to poor. The Center for 
Epidemiological Studies-Depression (CES-D) scale was used to categorize baseline depression 
among study participants with a cutoff at 16 points. 
Statistical Analyses 
 All statistical analyses were conducted in SAS 9.4 (SAS Institute, Inc., Cary, North 
Carolina) and figures were created in R using the ggplot2 package. Descriptive statistics were 
used to characterize the study population. In order to estimate the relationship between 
biomarkers of immune function and cognitive level and decline, we used linear mixed effects 
models with a random intercept and slope. To assess the relationship between the exposures and 
incident dementia, we used stratified cumulative incidence functions with death treated as a 
competing event. Inverse probability (IP) weights were used to account for censoring (variables 
included: exposure, educational attainment, age, diabetes, depression, self-rated health, and 
change in cognition between two prior waves) and confounding (variables included: educational 
attainment, biological sex, depression, and self-reported health). This minimally sufficient 
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adjustment set was determined a priori by DAG analysis. We further investigated potential 
biological interaction with salivary cortisol by including interaction terms between the exposure 
variables, salivary cortisol, and time. Separate models were used for each exposure measure: 1) 
crude models, 2) IP-weighted models, and 3) IP-weighted cortisol-interaction models. We also 
ran education-stratified models to investigate modification by educational attainment. Due to the 
sample size and limited power to detect interaction, we considered P < 0.10 statistically 
significant for interactions. 
5.3 Results 
Sample Characteristics 
 The 1,337 adults who met eligibility criteria and were included in our analysis were 
58.9% female and were on average 70 years old at baseline, with an age range of 60 to 93 years 
old. Thirty-two and a half percent of participants received a high school diploma or higher 
education. Just under 46% reported their health as “very good” or “excellent”, and 25.0% 
reported depressive symptoms at baseline. The mean 3MSE score at baseline was 87 (SD = 
10.3). 86.5% of the population was seropositive for HSV-1, while 84.5%, 29.3%, 91.1%, and 
33.5% were seropositive for CMV, VZV, H. pylori, and T. gondii, respectively. The mean (SD) 
values for cytokines CRP, IL-6, and TNF-alpha were 5.14 (5.7), 5.17 (7.0), and 4.07 (2.5), 
respectively. The complete demographic and social characteristics of our study population are 
described in Table 5.1. 
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Table 5.1. Baseline Sociodemographic, Immune, and 
Cognitive Characteristics of Eligible SALSA Participants, 
N = 1,337 
  Overall 
  N % 
    
Age (mean, range)  70 60, 93 
    
Sex (N, % Female)  787 58.9 
    
Education    
Less than 8th grade  663 49.6 
8th Grade diploma  239 17.9 
High School Diploma and above 435 32.5 
    
Self-rated Health    
Poor  97 7.3 
Fair  185 13.8 
Good  441 33.0 
Very Good  496 37.1 
Excellent  118 8.8 
    
Depressive Symptoms (N, % >=16) 334 25.0 
    
3MSE Score, Mean (STD)  86.7 (10.3) 
    
HSV1 (% seropositive)  946 86.5 
CMV  924 84.5 
VZV  320 29.3 
H. pylori  996 91.1 
T. gondii  366 33.5 
  missing infection data  244  
    
CRP, Mean (SD)  5.14 (5.7) 
missing  24  
IL-6, Mean (SD)  5.17 (7.0) 
missing  17  
TNF-alpha, Mean (SD)  4.07 (2.5) 
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Population Mean Cognitive Function 
Table 5.2 shows the association between continuous cytokine levels and population mean 
cognitive level over the course of follow-up before and after weighting. In IP-weighted models, 
we found that higher IL-6 and higher TNF-alpha were significantly associated with more errors 
on the 3MSE (i.e. lower cognitive scores). Each 1 unit increase in log(IL-6) was associated with 
an increase in the log of the errors of 0.0935 (95% CI: 0.055, 0.13). For each 1 unit increase in 
log(TNF-alpha), the log of the errors increased by 0.0944 (95% CI: 0.032, 0.157). Based on 
models including only age, these associations are roughly equivalent to cognitive changes of 
3.75 years. 
Table 5.3 shows the association between standardized IgG response to pathogens and 
population mean cognitive level over the course of follow-up before and after weighting. We 
found that higher CMV IgG was associated with more errors. Each 1 SD increase in CMV IgG 
was associated with a 0.0409 (95% CI: 0.013, 0.069) increase in the log errors. This pattern is 
borne out also when looking at the associations between CMV seropositivity and cognitive level 
(data in Supplemental Table 5.2). 
Interestingly, we also found that higher HSV-1 IgG was associated with fewer errors on 
the 3MSE in IP-weighted models. Each 1 SD increase in HSV-1 IgG was associated with 0.0308 
(95% CI: 0.004, 0.058) decrease in the log errors. This relationship, in the opposite direction of 
that hypothesized, is corroborated in results analyzing the association between HSV-1 
seropositivity and cognitive function, seen in Supplemental Table 2). CRP and VZV, T. gondii, 
and H. pylori IgG levels were not significantly associated, in either direction, with number of 
errors on the 3MSE. 
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Table 5.2. Fixed Effects Estimates from Linear Mixed Effects Models of Cytokines and Cognitive Decline in the SALSA, n=1,337 
   Crude Models  IP Weighted Models  Cortisol Interaction Models 
 Variable  Estimate 95% CI  Estimate 95% CI  Estimate 95% CI 
Interleukin - 
6 
Intercept  1.88 1.83 1.94  1.94 1.88 2.00  2.05 1.73 2.37 
IL-6  0.13 0.09 0.16  0.09 0.06 0.13  -0.16 -0.36 0.04 
IL-6*Age  0.00 -0.01 0.01  0.01 0.00 0.02  0.04 -0.03 0.10 
Age  0.01 -0.01 0.02  0.01 -0.01 0.02  -0.09 -0.19 0.01 
Age2  0.00 0.00 0.00         
Cortisol          -0.04 -0.17 0.08 
Age*Cortisol          0.04 0.00 0.08 
IL-6*Age*Cortisol 1         0.10 0.03 0.18 
IL-6*Age*Cortisol 0         -0.01 -0.04 0.01 
BIC  16578.2  15372.5  15376.5 
              
Tumor 
Necrosis 
Factor - alpha 
Intercept  1.84 1.76 1.92  1.95 1.86 2.03  1.74 1.33 2.16 
TNF-alpha  0.17 0.11 0.23  0.09 0.03 0.16  0.10 -0.23 0.43 
TNF-alpha*Age  0.00 -0.02 0.01  0.01 -0.01 0.03  -0.07 -0.17 0.04 
Age  0.02 -0.01 0.04  0.01 -0.01 0.03  0.04 -0.09 0.17 
Age2  0.00 0.00 0.00         
Cortisol          0.08 -0.08 0.25 
Cortisol*Age          -0.01 -0.06 0.04 
TNF-alpha*Cortisol          -0.01 -0.14 0.12 
TNF-alpha*Age*Cortisol         0.03 -0.01 0.07 
BIC  15641.6  14451.2  14466.5 
              
C-reactive 
Protein 
Intercept  2.02 1.99 2.05  2.04 2.00 2.08  1.98 1.76 2.19 
CRP  0.02 0.00 0.05  0.02 0.00 0.04  -0.16 -0.28 -0.04 
CRP*Age  0.00 -0.01 0.00  0.00 -0.01 0.00  -0.01 -0.04 0.03 
Age  0.02 0.01 0.03  0.02 0.01 0.03  -0.04 -0.10 0.02 
 
   
98 
Age2  0.00 0.00 0.00         
Cortisol          0.02 -0.06 0.11 
Age*Cortisol          0.03 0.00 0.05 
CRP*Cortisol          0.07 0.02 0.12 
CRP*Age*Cortisol          0.00 -0.01 0.01 
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Table 5.3. Fixed Effects Estimates from Linear Mixed Effects Models of Pathogens and Cognitive Decline in the SALSA, n=1,093 
   Crude Models  IP Weighted Models  Cortisol Interaction Models 
 Variable  Estimate 95% CI  Estimate 95% CI  Estimate 95% CI 
HSV-1 IgG 
Intercept  2.01 1.99 2.04  2.04 2.02 2.07  1.79 1.61 1.96 
HSV-1  -0.03 -0.06 -0.01  -0.03 -0.06 0.00  0.24 0.06 0.42 
HSV-1*Age  0.00 -0.01 0.01  0.00 -0.01 0.01  0.05 0.00 0.11 
Age  0.01 0.01 0.02  0.02 0.01 0.03  -0.04 -0.09 0.01 
Age2  0.00 0.00 0.00         
Cortisol          0.10 0.03 0.17 
Age*Cortisol          0.02 0.00 0.04 
HSV-1*Cortisol          -0.11 -0.18 -0.04 
HSV-1*Age*Cortisol          -0.02 -0.04 0.00 
BIC  13983.7  13135.5  13032.2 
              
CMV IgG 
Intercept  2.02 1.99 2.05  2.04 2.01 2.06  1.74 1.57 1.92 
CMV  0.07 0.05 0.10  0.04 0.01 0.07  0.12 -0.07 0.31 
CMV*Age  0.00 -0.01 0.01  0.00 0.00 0.01  -0.04 -0.10 0.01 
Age  0.01 0.00 0.02  0.02 0.01 0.03  -0.04 -0.09 0.01 
Age2  0.00 0.00 0.00         
Cortisol          0.11 0.05 0.18 
Age*Cortisol          0.02 0.00 0.04 
CMV*Cortisol          -0.03 -0.10 0.04 
CMV*Age*Cortisol          0.02 0.00 0.04 
BIC  13959.3  13267.3  13172.2 
              
VZV IgG 
Intercept  2.01 1.98 2.04  2.03 2.01 2.06  1.81 1.63 1.98 
VZV  -0.05 -0.08 -0.03  -0.02 -0.05 0.01  0.02 -0.16 0.20 
VZV*Age  0.00 -0.01 0.01  0.00 -0.01 0.01  0.00 -0.06 0.05 
Age  0.01 0.01 0.02  0.02 0.01 0.03  -0.04 -0.09 0.01 
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Age2  0.00 0.00 0.00         
Cortisol          0.09 0.02 0.16 
Age*Cortisol          0.02 0.00 0.04 
VZV*Cortisol          -0.01 -0.08 0.06 
VZV*Age*Cortisol          0.00 -0.02 0.02 
BIC  13973.4  13237.6  13145.4 
              
H. pylori 
IgG 
Intercept  2.01 1.99 2.04  2.04 2.02 2.07  1.74 1.57 1.92 
H. pylori  0.05 0.02 0.07  0.03 0.00 0.05  0.05 -0.13 0.23 
H. pylori*Age  -0.01 -0.02 0.00  -0.01 -0.02 0.00  -0.04 -0.10 0.02 
Age  0.01 0.01 0.02  0.02 0.01 0.03  -0.03 -0.09 0.02 
Age2  0.00 0.00 0.00         
Cortisol          0.12 0.05 0.18 
Age*Cortisol          0.02 0.00 0.04 
H. pylori*Cortisol          -0.01 -0.08 0.06 
H. pylori*Age*Cortisol         0.01 -0.01 0.03 
BIC  13972.8  13160.2  13059.6 
              
T. gondii 
IgG 
Intercept  2.01 1.99 2.04  2.04 2.01 2.07  1.78 1.61 1.95 
T. gondii  0.05 0.02 0.08  -0.01 -0.04 0.01  -0.01 -0.18 0.15 
T. gondii*Age  0.00 -0.01 0.00  0.00 -0.01 0.01  0.00 -0.05 0.05 
Age  0.01 0.01 0.02  0.02 0.01 0.03  -0.04 -0.09 0.02 
Age2  0.00 0.00 0.00         
Cortisol          0.10 0.03 0.17 
Age*Cortisol          0.02 0.00 0.04 
T. gondii*Cortisol          0.00 -0.06 0.07 
T. gondii*Age*Cortisol         0.00 -0.02 0.02 
BIC   13974.3   13198.3   13108.0 
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Cognitive Change over Time 
Tables 5.2 and 5.3 also show the association between continuous cytokine and pathogen 
IgG levels and cognitive decline over the course of follow-up before and after weighting. H. 
pylori, however, was significantly associated with rate of cognitive change over follow-up; for 
each year of age, a 1 SD higher H. pylori IgG level was associated with 0.0086 (95% CI: 0.001, 
0.016) fewer log errors. Full results can be seen in Table 5.3. However, neither IL-6 nor TNF-
alpha were significantly associated with the rate of cognitive change over follow-up, nor was 
CRP. Table e-1 shows results for the association of categories of high or low cytokine levels 
with cognitive level and change over follow-up. Full results can be seen in Table 5.2. Neither 
HSV-1 nor CMV IgG levels were associated with rate of decline, nor were VZV or T. gondii.  
Cortisol Interactions 
 Overall, higher cortisol levels were associated with lower cognitive function in this 
population. We found statistically significant interactions (p < 0.10) between cortisol and HSV-
1, IL-6, and CRP for cognitive level as well as between cortisol and IL-6 and HSV-1 for rate of 
decline. These results are shown as ‘Cortisol Interaction Models’ in Tables 5.2 and 5.3 and 
results for HSV-1, CRP, and IL-6 are demonstrated visually in Figure 5.1. Those with higher 
cortisol (e.g. log cortisol values equal to 3), exhibited, on average, more errors on the 3MSE than 
those with lower cortisol. For younger age groups, this relationship did not appear to change 
substantially with increasing levels of biomarkers. However, at ages 80 and above, the predicted 
log(3MSE errors) were different by level of biomarker. In Figure 5.1a we see that as levels of 
IL-6 increase, 3MSE errors increase as well, though the change is steeper for those with lower 
cortisol. In Figure 5.1c we see that as age increases, the HSV-1 IgG and 3MSE error relationship 
becomes stronger, with those with high cortisol actually decreasing in errors while those with 
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lower cortisol increasing. For IL-6, CRP, and HSV-1, the relationship between biomarker and 
cognition was similar by levels of cortisol for younger ages. 
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Figure 5.1. Associations of Immune Biomarkers and 
Cognition by Levels of Cortisol. This figure demonstrates 
relationship between continuous level of immune biomarker and 
log of the errors on the Modified Mini-Mental State Examination 
(3MSE). Output are the predicted 3MSE errors for incremental 
increases in biomarkers, categorized by estimated cortisol levels 
and paneled by age. Panel a) shows the relationships for IL-6, 
Panel b) shows the relationships for CRP, and Panel c) shows 
the relationships for HSV-1 IgG. All predicted values come from 
final, IP-weighted cortisol interaction linear mixed effects 
regression models. Only those biomarkers for which there was a 
statistically significant interaction with cortisol are shown here.  
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Figure 5.2. Cumulative Incidence of 
Dementia by Immune Biomarkers. 
This figure demonstrates the 
relationship between category of 
immune biomarker and the incidence 
of dementias. Output are the IP-
weighted cumulative incidence 
functions (95% CIs in grey) for each 
biomarker. Panel a) shows the 
relationships for pathogen 
seropositivity and Panel b) shows the 
relationships for high and low levels of 
cytokines. All values come from final, 
IP-weighted cumulative incidence 
models estimated using the Aalen-
Johansen estimator. 
 
   105 
Incidence of Dementia 
 IP-weighted cumulative incidence functions for the age range of the study population 
over follow-up show no statistically significant relationship between pathogen seropositivity and 
incidence of dementia. Figure 5.2b shows the full CIFs for each pathogen. There is some 
indication that H.pylori seropositivity may be associated with decreased incidence of dementia. 
However, due to the small number of incident dementia cases in this sample (n = 112 total but 
only 78 among those with infection data) and the high prevalence of the pathogens, particularly 
CMV and HSV-1, our analyses were underpowered to detect associations here. Similarly, there 
was no statistically significant associations between IL-6, TNF-alpha, or CRP and the incidence 
of dementia. The confidence intervals for each CIF substantially overlap indicating no significant 
association. Figure 5.2b shows the full CIFs for each cytokine.  
Modification by Educational Attainment 
 We found statistically significant interactions between education and several immune 
biomarker on mean cognitive function investigated in this analysis. For IL-6 and TNF-alpha, the 
relationship with 3MSE score was only statistically significant among those with less than an 8th 
grade education. The magnitude of the association was also larger for those in this low education 
category. VZV and H. pylori also exhibited modification by educational attainment, with a 
similar pattern of a more negative association among those with low educational attainment, 
though the relationship even became positive among those with higher education. The positive 
association between H. pylori and 3MSE score is seen only among those with a high school 
diploma or more education. Furthermore, the relationship between IL-6 and rate of cognitive 
decline was significantly modified by educational attainment. The full results of our analysis of 
modification can be found in Tables 5.4 and 5.5. 
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Table 5.4. Education-stratified Fixed Effects Estimates from Linear Mixed Effects Models of Cytokines and Cognitive Decline in the 
SALSA, n=1,337 
   < 8th Grade  8th Grade Diploma  High School Diploma  educat-interaction  
p-value  Variable  Estimate 95% CI  Estimate 95% CI  Estimate 95% CI  
Interleukin - 6 
Intercept  2.38 2.31 2.45  1.92 1.81 2.03  1.50 1.41 1.59   
IL-6  0.09 0.05 0.14  0.06 -0.01 0.14  0.06 -0.01 0.12  <.0001 
IL-6*Age  0.01 0.00 0.03  0.00 -0.01 0.02  -0.01 -0.03 0.01  0.0045 
Age  0.00 -0.02 0.02  0.01 -0.01 0.04  0.02 0.00 0.04  0.0312 




Intercept  2.21 2.10 2.32  2.07 1.91 2.24  1.50 1.38 1.62   
TNF-alpha  0.23 0.15 0.32  -0.06 -0.18 0.06  0.05 -0.04 0.14  <.0001 
TNF-alpha*Age  0.00 -0.02 0.02  0.01 -0.02 0.04  -0.01 -0.03 0.02  0.8268 
Age  0.02 -0.01 0.04  0.01 -0.03 0.05  0.02 -0.02 0.05  0.5979 
                
C - Reactive 
Protein 
Intercept  2.49 2.45 2.53  1.93 1.86 2.01  1.58 1.53 1.63   
HSCRP  0.02 -0.01 0.04  0.07 0.02 0.12  -0.01 -0.05 0.02  <.0001 
HSCRP*Age  0.00 -0.01 0.01  -0.01 -0.02 0.00  0.00 -0.01 0.01  0.2107 




   
107 
Table 5.5. Education-stratified Fixed Effects Estimates from Linear Mixed Effects Models of Pathogens and Cognitive Decline in the 
SALSA, n=1,093 
   < 8th Grade  8th Grade Diploma  High School Diploma  educat-interaction  
p-value  Variable  Estimate 95% CI  Estimate 95% CI  Estimate 95% CI  
HSV-1 
Intercept  2.48 2.45 2.52  2.00 1.94 2.05  1.56 1.52 1.60   
HSV-1  -0.06 -0.09 -0.02  -0.01 -0.05 0.04  0.00 -0.04 0.04  0.3462 
HSV-1*Age  0.00 -0.01 0.01  0.00 -0.01 0.01  0.00 -0.01 0.01  0.9625 
Age  0.02 0.01 0.03  0.02 0.01 0.03  0.01 0.00 0.02  <.0001 
                
CMV 
Intercept  2.49 2.45 2.52  2.00 1.95 2.06  1.55 1.51 1.59   
CMV  0.05 0.01 0.09  0.06 0.00 0.12  0.01 -0.03 0.05  0.5595 
CMV*Age  0.00 -0.01 0.01  -0.01 -0.02 0.01  0.01 0.00 0.02  0.1859 
Age  0.02 0.01 0.03  0.02 0.01 0.03  0.01 0.00 0.02  <.0001 
                
VZV 
Intercept  2.47 2.44 2.51  2.00 1.94 2.06  1.55 1.51 1.59   
VZV  -0.06 -0.10 -0.02  0.08 0.00 0.15  0.03 -0.01 0.06  <.0001 
VZV*Age  0.00 -0.01 0.01  -0.01 -0.02 0.01  0.01 0.00 0.02  0.8001 
Age  0.02 0.02 0.03  0.02 0.01 0.03  0.01 0.00 0.02  <.0001 
                
H. pylori 
Intercept  2.49 2.45 2.52  2.00 1.94 2.05  1.57 1.53 1.61   
H. pylori  -0.01 -0.04 0.03  -0.05 -0.11 0.01  0.08 0.04 0.12  0.0042 
H. pylori*Age  0.00 -0.01 0.01  -0.01 -0.03 0.00  0.00 -0.01 0.01  0.3767 
Age  0.02 0.01 0.03  0.02 0.01 0.03  0.01 0.00 0.02  <.0001 
                
T. gondii 
Intercept  2.49 2.45 2.52  1.98 1.93 2.04  1.56 1.52 1.60   
T. gondii  -0.03 -0.06 0.00  0.06 0.00 0.11  -0.03 -0.08 0.01  0.2411 
T. gondii*Age  0.00 -0.01 0.01  -0.01 -0.02 0.01  -0.01 -0.02 0.01  0.0363 
Age   0.02 0.01 0.03   0.02 0.01 0.03   0.01 0.00 0.02   <.0001 
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5.4 Discussion 
We found that overall, IL-6, TNF-alpha, and CMV IgG levels were associated with 
poorer cognitive function in this study population. The magnitude of these associations was 
roughly equivalent to the change in cognitive function seen over 3.75 years of age in our study 
population for the cytokines and 1.5 years for CMV. Only H. pylori IgG was significantly 
associated with the rate of cognitive change over 10 years of follow-up, with a 1 SD increase H. 
pylori IgG associated with a small but statistically significantly higher number of log 3MSE 
errors (estimate: 0.0086 (95% CI: 0.001, 0.016)) per year of age. Moreover, increases in HSV-1 
IgG, were associated with better cognitive function. Additionally, IL-6, TNF-alpha, and HSV-1 
interacted with cortisol to alter the relationships with cognitive level and age. Overall, we found 
that higher cortisol levels were associated with lower cognitive function in this population and 
that cortisol interacted with HSV-1, IL-6, and CRP for cognitive level as well as with IL-6 and 
HSV-1 for rate of decline. For younger age groups, this relationship did not change much with 
increasing levels of biomarkers. However, at ages 80 and above, cognitive function is different 
by level of immune biomarker. As levels of IL-6 increase, cognitive function decreases, though 
more steeply for those with lower cortisol, and as age increases, the slope of the HSV-1 IgG and 
3MSE error relationship becomes stronger, with those with high cortisol actually decreasing in 
errors while those with lower cortisol increasing. Furthermore, we found that the associations 
between immune biomarkers and cognitive trajectories were modified by educational attainment, 
a proxy for cognitive reserve, with stronger associations among those with lower educational 
attainment. We did not find any statistically significant associations between peripheral immune 
system biomarkers and dementia incidence.  
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 The findings of negative associations between biomarkers of immune function and 
cognition are consistent with the previous literature indicating associations between biomarkers 
of immune function and cognition. Several studies have shown that dementia patients have 
higher CRP levels in the blood compared to non-dementia patients, as well as similar 
associations between CRP and cognitive level.95,100,101,103,104,106 However, both cross-sectional 
and longitudinal studies have shown mixed results, as do our analyses, with several reporting no 
such associations.108,109,111-114 These associations and mixed results have been seen with other 
inflammatory markers, including cytokines (i.e. IL-6 and TNF-α) 97,116-118,122 and CMV IgG 
response.123 Our results here are also mixed, with some cytokines and infection IgG responses 
being associated with worse cognition, but with some not being associated with cognition at all, 
and even one (HSV-1) associated with better cognition. However, as much of the literature in 
this area focuses on CRP only, it is important that we have investigated a more comprehensive 
set of indicators of peripheral immune function than previous research. 
The research on the relationship between immune system aging and cognition is based on 
biological mechanisms that have been studied extensively in humans and animal models.93,124-
126,131 As the human brain ages, the presence of misfolded proteins, free radicals, and epigenetic 
changes increase125,126 and microglia become senescent, leading to an elevation in the production 
of pro-inflammatory cytokines, impaired phagocytosis, reduced motility, and reversing the 
demyelination of axons, which is a common change in neurodegenerative diseases.124,126 The 
presence of misfolded proteins (such as amyloid-	") elevates production of pro-inflammatory 
cytokines in microglia,93,125,126 but may additionally inhibit the ability of microglia to secrete 
anti-inflammatory cytokines.126 However, there is also evidence that an inflammatory response 
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activates microglia and astrocytes, leading to increased production of amyloid-β, and as such, it 
is unclear which is the triggering event for neurodegeneration leading to AD.124,131 
Studies comparing the immune profiles of individuals with AD to those of healthy 
controls have found evidence of advanced peripheral immunosenescence in individuals with AD, 
though these studies are small and results have been conflicting.132-134 While advanced peripheral 
immunosenescence could itself be integral in the pathogenesis of dementia, it would require 
accompanying perturbations in the blood brain barrier (BBB) to allow movement of immune 
molecules into the central nervous system (CNS). Disruptions in the BBB can lead to increased 
permeability allowing the transport of aged immune cells, inflammatory cytokines and 
chemokines, and infectious agents, all of which are critical to the disease process.  
As cytokines have neuromodulatory properties including roles in neurogenesis and 
neuronal survival,136 the imbalance of pro- and anti-inflammatory cytokines resulting from 
senescent microglia can lead to physiological changes in the brain. The overproduction and 
extended presence of pro-inflammatory cytokines in the brain can further damage the BBB,136 
which deteriorates naturally with increasing age.93 Leakage in the BBB has been observed early 
on in cases of AD93,137 and allows the passage of peripheral immune cells and inflammatory 
mediators into the central nervous system.124 While the BBB naturally deteriorates with age,93 
environmental stimuli can also accelerate this process. However, it could be that the natural 
deterioration of the BBB that is in seen with age is in part driven by both peripheral and central 
immunosenescence. For example, as cytokines have neuromodulatory properties including roles 
in neurogenesis and neuronal survival,135,136 the imbalance of pro- and anti-inflammatory 
cytokines resulting from senescent microglia can lead to physiological changes in the brain. The 
overproduction and extended presence of pro-inflammatory cytokines in the brain can further 
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damage the BBB.136 Specifically, IL-β activates IL-1 receptor 1 (IL-1R1), which can induce the 
deterioration of membrane phospholipids with as few as 2-3% of the receptors occupied.136,138 
The imbalance of cytokines can alter neurotransmitter release, astrocyte function, and the activity 
of voltage-gated ion channels and receptor-coupled ion channels,136  which has been shown to 
have long-term effects on cognition, such as impairing reversal learning,136,139 disrupting 
avoidance learning in adults,136,140 and altering neurotransmission and plasticity in the 
hippocampus and pre-frontal cortex, though this evidence is largely of exposure to immune 
activation occurring during the prenatal period.136,143-145 Cortisol binding to immune cells may 
alter this relationship, as demonstrated in our analyses. Our results provide further evidence that 
measurements of peripheral immune function, including cytokines and persistent pathogen IgG 
response, may lead to and therefore be indicative of decreased cognitive function and/or 
accelerated cognitive decline in populations over 65 years old. 
Our study had several strengths, including the participants, representative of the 
Sacramento, CA area LatinX population, and longitudinal data covering up to 10 years of follow-
up for participants. The availability of baseline IgG response to five common persistent 
pathogens as well as three cytokines allowed us to examine a better picture of participants’ 
immune function, as opposed to a single marker. Additionally, the use of markers of both the 
adaptive and innate immune system captures a wider spectrum of immune function in the 
participants.  
However, our study does have limitations. We expect measurement error in the cognitive 
measures, both measured cognitive level and incidence of dementia. Also, the low incidence of 
dementia limits our power to detect differences by biomarker. The 3MSE collected over the 
course of follow-up has limited sensitivity to detect differing levels of cognitive function among 
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study participants or decline of function in all cognitive domains within an individual, though it 
is widely used in large cohort studies. The 3MSE is also subject to retest effects whereby the 
participant may become familiar with the test and actually appear to improve over subsequent 
administrations, or remain constant over subsequent administrations, rather than decline in 
performance, as would be expected over time with cognition. A final measurement error 
limitation is in our use of biomarkers in this study. All biomarkers are subject to imperfect 
sensitivity and specificity as well as further error induced by the natural fluctuation of these 
biological markers in humans, which can depend on time of day of measurement,213 recent 
exercise,214 and diet.215 All biomarkers gathered in SALSA were taken at a fasting time period 
and cortisol measurements were all taken as a waking sample, offsetting concerns about 
consistency in the timing of these measures and fasting influences. However, the magnitude of 
cortisol change over the course of the day may be a better indication of the physiologic 
embodiment of stress. SALSA does not information on particpants’ cortisol levels throughout the 
day, so we were unable to use that measure. The small magnitude of the associations may be a 
result of survival bias in our dataset. It is possible that those who were the least healthy and had 
higher cytokine levels and higher pathogen IgG levels did not survive to join the study. Finally, 
there is potentially bias in our results due to unmeasured confounding.  
Functional and cognitive aging present a unique health care challenge for the country, 
given that an estimated 5.2 million people over 65 years in the U.S. had an ADRD as of 2016.1 
In 2016 alone, the U.S. spent $162.7 billion on long-term healthcare, which is approximately 5% 
of all U.S. healthcare costs.168 This burden will only continue to grow through the next several 
decades, including in the Hispanic population, with an estimated 14 million cases of AD 
projected in the U.S. by 2050,1 underscoring the importance of long term, preventive measures. 
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Besides introducing a new burden on the healthcare system simply by requiring extensive care 
for routine activities, those suffering from dementia are at an elevated risk of several other 
negative health outcomes due to their increased risk of exposure to infections and diminished 
ability to care for themselves, contributing significantly to healthcare costs.169 Those suffering 
from dementia and other memory disorders are more likely to have comorbidities such as 
diabetes, infection, injury, and depression.170-172 All of these secondary health conditions that 
occur partially as a result of the cognitive and functional impairment of the elderly exert an 
additional burden on the healthcare system. As such, it is imperative that researchers investigate 
novel determinants of dementias. It will continue to be important to examine factors that either 
accelerate cognitive decline, increase risk of dementia, or both, in order to identify potential 
targets for intervention and prevention. Of note, Mexican Americans experience a 
disproportionate prevalence of these persistent infections than the white non-Latinx US 
population,216 which may enhance associations we observed, compared to a nation-wide samples. 
Thus, our results have implications for the prevention and delay of cognitive decline, but 
not the incidence of dementia, in elderly populations. Currently, there are documented disparities 
in the distribution of AD and other dementias across the US, including by sex, race and ethnicity, 
income, and educational attainment.4-6 All of these factors are deeply intertwined and difficult to 
disentangle. However, mechanisms associated with immune function could present a target for 
intervention, to delay the onset of cognitive impairment and slow decline. The finding of an 
association between H. pylori and cognitive decline in the opposite direction of what we 
expected weakens the strength of this view, though. Further investigation is needed as to why 
this particular pathogenic immune response association may be opposite the other pathogens. As 
dementia is a progressive disease, prevention prior to onset is essential to reducing the 
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subsequent health care burdens. Understanding the mechanisms through which these social and 
environmental factors may interact to affect cognitive decline and onset of dementia will move 
the field forward and allow us to design targeted interventions to reduce disparities in and the 
overall incidence of dementia. 
 
   115 
CHAPTER 6: DISCUSSION 
 This dissertation aimed to investigate the pathways and associations within a conceptual 
framework of lifecourse psychosocial stressors and their embodiment and association with later 
life cognitive function and dementia incidence. Further, this dissertation investigated the 
association between biomarkers of immune function and cognition, as these biomarkers may be 
an important pathway through which psychosocial stressors act in influencing pathology 
implicated in AD and cognitive impairment. Moreover, this work aimed to determine whether 
educational attainment, as a marker of cognitive reserve, was an effect measure modified of the 
relationships between each exposure (e.g. psychosocial stressors, biomarkers) and cognitive 
outcomes. To accomplish these aims, we utilized the Health & Retirement Study, the largest on-
going nationally representative longitudinal survey of older adults in the U.S, .and the 
Sacramento Area Latino Study on Aging, a prospective, observational community-based cohort 
study of 1,789 self-designated Latino adults in the Sacramento Valley, CA area. 
This dissertation specifically investigated the experience of 10 traumatic events 
experienced across the lifecourse, how the timing of those events impacts cognition in later life, 
and whether biomarkers of peripheral immune function are associated with cognition and 
dementia as well. Chapter 6 reviews the results that were found in Chapters 4 and 5, discusses 
the strengths and limitations of this study, and describes the public health impact and future 
directions of this research. 
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6.1 Summary of Findings 
 This dissertation found that lifetime experience of traumatic events are associated with 
level of cognitive function and rate of cognitive decline but not associated with the incidence of 
dementia in up to 10 years of a US population-based survey of adults over the age of 65. 
However, the association was in the opposite direction of the hypothesis. Having experienced 
any number of traumatic events during the lifecourse is associated with a higher cognitive score. 
It is also associated with faster cognitive decline, as hypothesized. We found interesting trends 
when investigating life-period specific occurrence of these events and effect measure 
modification by educational attainment. Those who experienced traumatic events in late life had 
higher cognitive function, and the association of accumulated lifecourse events with rate of 
decline appeared to be largely drive by events experienced in late life. Experiencing events in 
early life or young adulthood was also associated with higher cognitive function, but the 
association was smaller in magnitude. The observed relationships were modified by the 
educational attainment of participants. Broadly, the associations were strongest among those 
with the lowest educational attainment (i.e. less than a high school diploma).  
However, the sensitivity analysis investigating each individual event’s association with 
cognitive function and decline may be the most important for guiding future research. The type 
of traumatic event is important and determines not only the strength but also the direction of the 
association with cognitive trajectories. Two events, the death of a child and being the victim of a 
serious physical assault, were associated with lower cognitive function. On the other hand, being 
in a major natural disaster or having a close relation experience a life-threatening illness or 
accident were associated with higher cognitive function. While understanding the reasons behind 
the different directions in association by event type is beyond the scope of this dissertation, we 
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can theorize why they may be grouped in this way. The two events associated with higher 
cognitive function are both events that, while traumatic, also cognitively stimulate the individual 
due to the need to relocate, rebuild, or support a loved one. The two events associated with lower 
cognitive function on the other hand, death of a child and being the victim of a physical attack, 
do not necessarily require that kind of cognitive work in their aftermath. 
Using the SALSA, a study of Latinos over the age of 60 in the Sacramento, CA area, we 
also found that overall, IL-6, TNF-alpha, and CMV IgG levels were associated with poorer 
cognitive function in this study population. This association between immune markers and 
cognition was in the expected direction. The magnitude of these associations was roughly 
equivalent to the change in cognitive function seen over 3.75 years of age in the SALSA 
population for the cytokines and 1.5 years for CMV. Additionally, we found that higher cortisol 
was associated with lower cognitive function in this population and that cortisol interacted with 
HSV-1, IL-6, and CRP for cognitive level as well as with IL-6 and HSV-1 for rate of decline. 
For younger age groups, this relationship did not change much with increasing levels of 
biomarkers. However, at ages 80 and above, cognitive function is different by level of immune 
biomarker. As levels of IL-6 increased, cognitive function decreased, though more steeply for 
those with lower cortisol, and as age increased, the slope of the HSV-1 IgG and 3MSE error 
relationship becomes stronger, with those with high cortisol actually decreasing in errors while 
those with lower cortisol increasing. We did not find any statistically significant associations 
between peripheral immune system biomarkers and dementia incidence. Finally, we found that 
educational attainment modifies this relationship, too. The observed relationships were stronger 
among those with lower educational attainment consistent with our findings from aim 1. 
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 It is important to note that these results are only applicable to populations over the age of 
60 and 65 years, as those are the populations included. Particularly for the investigation into 
lifecourse experiences of traumatic events, there is a large time period between the exposure and 
the outcome, during which people may have been selected out of the study population. The 
selection bias likely introduced by this phenomenon is common to lifecourse research, and will 
be further discussed in both the limitations and the future directions sections. 
6.2 Strengths and Limitations 
While we used well-designed longitudinal cohort studies as the source of data for all 
analyses in this dissertation, the project is still subject to several limitations, common to most 
cohort studies of aging populations and cognitive impairment. 
We expect measurement error in the cognitive measures and incidence of dementia. The 
cognitive measures collected over the course of follow-up, including both the HRS-TICS and the 
3MSE are subject to retest effects whereby the participant may become familiar with the test and 
actually appear to improve over subsequent administrations, or remain constant over subsequent 
administrations, rather than decline in performance, as would be expected over time with 
cognition. However, this limitation is addressed as well as it can be in the design of HRS. The 
HRS addresses this issue by providing different forms of the recall tests at subsequent waves, to 
mitigate improvement from learning the test.217 However, there is likely still be some of this 
effect in our data, and we therefore acknowledge this as a limitation in the discussion for 
analyses using either study. At the same time, neurologists and others have argued that a learning 
effect is not a true bias because all individuals will have some capacity to learn the test and the 
differential effects of this learning “bias” should be similar across groups with similar 
demographic characteristics.  Therefore, adjusting for factors such as education level and 
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following individuals over longer periods of time, greatly offsets concerns related to this 
potential bias. 
Furthermore, the abridged (35 point) version of the TICS that is used in the HRS does not 
provide as sensitive a measure of cognition as the full TICS (50 points) or the 3MSE (100 
points). As the HRS does not have clinically adjudicated diagnoses of dementia in the cohort, our 
algorithm to detect dementia at each wave in participants provides another limitation to our 
study. We addressed this limitation by incorporating both cognitive data and ADLs and IADLs 
into an algorithm to predict likelihood of dementia at each timepoint, as described by Hurd, et al 
and Gianattasio et al.183,184 We also required that a participant remain below the threshold for 
dementia for the remainder of follow-up in order to be classified as demented.  
Measurement error in our exposure measure traumatic events across the lifecourse may 
introduce bias into our results. The measure is compiled from self-reported data subject to recall 
bias. However, as the events participants are recalling are particularly stressful or traumatizing, 
the amount of inaccurate recall is likely small. There is also a high likelihood that we did not 
capture all of the types of events that could be experienced throughout one’s life that would 
induce a higher than population-average level of stress. The human lifecourse presents the 
opportunity for a vast array of stressful experiences, and while the HRS did its best to capture the 
most powerful ones in the Psychosocial and Lifestyle Questionnaire, there is inevitably be some 
that were missed. Therefore, our exposure variable likely does not accurately capture the full 
range of stress experienced across the lifecourse for each participant.  
A final measurement error limitation is in our use of biomarkers in this study. All 
biomarkers included are subject to imperfect sensitivity and specificity, as well as further error 
induced by the natural fluctuation of these biological markers in humans, which can depend on 
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time of day of measurement,213 recent exercise,214 and diet.215 All biomarkers gathered in the 
SALSA study were taken at a fasting time period and cortisol measurements were all taken at a 
waking sample, offsetting concerns about consistency in the timing of these measures and fasting 
influences. 
An important limitation, particularly relevant to Chapter 4 and research involving 
lifecourse exposures and late-life outcomes, is selection bias. The population we are able to 
investigate in this dissertation includes only those individuals who survived to ages 60 or 65 and 
were community-dwelling and healthy enough to be enrolled into their respective studies. This 
leaves a large amount of time between exposure and study enrollment, particularly for early-life 
and young-adulthood traumatic events. During the period between exposure and study 
enrollment, there may have been unobserved health impacts on the exposed group. Those who 
were exposed may have been less likely to enroll in the HRS, or they may even have been less 
likely to survive until the age of eligibility. Therefore, those who were most impacted by the 
exposure of interest may not even be included in our study population. 
The HRS is designed to be representative of the over 50 U.S. population. However, our 
analytic cohort will be restricted based on availability of psychosocial data and the absence of 
dementia at baseline. Therefore, it is unlikely that our restricted cohort remained representative of 
the U.S. Finally, there is likely bias in our results due to unmeasured confounding. The SALSA is 
a study of Latinos in the Sacramento, CA area, and therefore generalizable only to that population. 
This dissertation had several strengths, including using two population-based 
observational cohort studies to investigate these lifecourse processes, with data covering up to 10 
years of follow-up for participants. This is a longer period of cognitive follow-up than most prior 
studies have been able to investigate. The availability of detailed exposure measurements in both 
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the SALSA and HRS, was also a strength. The Psychosocial & Lifestyle Questionnaire in HRS 
asked detailed questions about a wide range of psychosocial stressors, and allowed us to study 
the importance of not only the accumulation of traumatic experiences but also the timing of the 
experiences. Baseline IgG response to five common persistent pathogens as well as three 
cytokines in the SALSA allowed us to examine a better picture of participants’ immune function, 
as opposed to a single marker.  
6.3 Public Health Implications 
Dementia, including AD and VaD are rapidly increasing in prevalence in the U.S., and as 
of 2016 cost the U.S. $162.7 billion in long-term healthcare, which is approximately 5% of all 
U.S. healthcare costs. Researchers have estimated that by 2050, there may be as many as 14 
million cases of AD in the U.S., and as such, prevention of or delay of onset of cognitive decline 
and dementia are public health priorities. Currently, there are documented disparities in the 
distribution of AD and other dementias across the population, including by sex, race and 
ethnicity, income, and educational attainment.4-6 Research further suggests that psychosocial 
stressors beyond socioeconomic status contribute to rates of decline and the onset of dementias. 
All of these factors are deeply intertwined and difficult to disentangle. However, understanding 
what characteristics of populations alter their cognitive trajectories in late life and risk of 
dementia is essential to building prevention techniques. The research conducted here has 
contributed to a better understanding of how experiences that occur across the lifecourse 
contribute to later life cognitive health as well as understanding the pathways through which 
these relationships occur. We investigated how much they contributed, and how patterns of 
exposure across the lifecourse, including testing whether various trajectories, sensitive periods, 
or simple accumulation matter most. Accordingly, a lifecourse epidemiology approach is 
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essential for a more nuanced understanding of dementia etiology in the U.S. and the mechanisms 
that drive disparities. To address this critical gap in knowledge, we examined the effect of 
psychosocial stressors experienced across the lifecourse and immune function on cognitive 
decline and dementia in the U.S. 
The accumulation of psychosocial stressors is a complex issue influenced by sex, 
race/ethnicity, SES, early-life living conditions, and educational attainment. Despite this 
complexity, because cognitive decline and ADRDs are a major health issue that requires high 
priority for prevention at the individual and community level, delving into these relationships is 
critical, and our study moved the research forward in pursuit of eventually informing 
recommendations for identifying high risk individuals and prevention targets. Current cognitive-
decline and dementia delay prevention recommendations from the Alzheimer’s Association 
include lifestyle changes such as increasing exercise (both physical and cognitive), eating 
healthy, getting enough sleeping, and quitting smoking.199,200 Current screening for dementia 
involves primarily relying on a significant other or their PCP to identify cognitive deficits before 
referral to a neurologist, psychologist, or geratrician.201 Our study provided information 
regarding how patterns of stressor experiences across the lifecourse may affect cognitive decline 
and onset of dementia. This information can also be used to understand the etiology of dementias 
as well as in identifying individuals at risk of dementias earlier than only cognitive testing can. 
Furthermore, this study suggests that, because trauma may be structural and patterned by 
structural factors in society (e.g. those in poorer neighborhoods being more likely to be affected 
by a natural disaster and those with less access to healthcare more likely to experience the death 
of a loved one), our solutions for prevention and delay should also include structural components 
rather than just individual behaviors. 
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6.4 Future Research 
 The high and increasing burden of cognitive impairment and dementia in the U.S. is not 
adequately explained by established cognitive risk factors. However, psychosocial stressors 
accumulated across the lifecourse have been identified as potential factors contributing to 
cognitive decline and dementia. These are dynamic factors that accumulate over the lifecourse, 
especially among those of lower social status. The extant literature in this area is limited in the 
following ways: 1) much of the prior research into these relationships has been limited by small 
sample sizes15,22,23,31,37-39 and restricted populations;14,16,17,33,37,173) most of the prior research that 
has focused on psychosocial stressors and cognition utilizes limited measures of psychosocial 
stress in that they do not incorporate information on when in the lifecourse the stressor occurred. 
Most studies focus on either childhood-specific events only,14,20 very recent events,38 or events at 
any point with no consideration given to the timing of those events;174,175 and 3) prior studies of 
discrimination or traumatic events and cognition have investigated cognitive decline over much 
shorter periods of time, from six months to a few years, with only one, the longest, including up 
to eight years of follow-up.21 Most of the previous research is therefore limited in temporal 
inference and power to detect change over time. This dissertation moved the research forward by 
being the first large-scale population-based investigation into these lifecourse processes; 
identifying which life period the events took place in and investigating whether stressors follow 
the accumulation of risk model or sensitive period model; and, while not a full 10 years for each 
participant, providing a time frame during which significant cognitive decline can occur in a 
single individual as well as significant diversion in cognitive decline trajectory can occur among 
participants. 
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However, this dissertation has not addressed many of the other limitations in this field of 
research, and future research should attempt to address them. As discussed in Chapter 4, a major 
limitation of cognitive research, especially when combined with lifecourse exposures, is the lack 
of data in younger cohorts. Cognitive research should ideally cover the entire lifecourse, so that 
researchers can fully understand when cognitive decline begins, when it traditionally accelerates, 
and what factors lead to deviation from those population averages. A lifecourse approach to 
cognition- and ADRD-focused longitudinal cohort studies would also allow researchers to 
understand how events experienced early on in life may impact health to such an extent that 
participants are selected out of studies only enrolling older participants. 
Findings from this study, particularly those discussed in Chapter 4, make it clear that the 
long-term bodily impact of psychosocial stressors can depend on both timing and type of event. 
While there may be cumulative effects resulting from multiple stressors, research on 
psychosocial stressors, including this dissertation, has been primarily limited to unidimensional 
representations of psychosocial stress, such as financial strain, social isolation, or traumatic 
events. Modelling of psychosocial stressors in population health research typically captures only 
one of these components of stress, and rarely if ever captures both stressors and social 
environment. However, all of these dimensions and more have been shown to be associated with 
health outcomes. Furthermore, the questions asked of participants typically refer to a narrow 
window of time in their life, such as the last three months, five years, or before the age of 18, 
even though we know that events occurring at many points across the lifecourse matter. In order 
to fully understand the relationship between these exposures and health outcomes, we must 
create more comprehensive measures of psychosocial stressors. 
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Additionally, rarely do psychosocial stressors occur in isolation, without a context of 
social resources that the individual has or in the absence of other stressors. Measurement and 
analysis of single domains of psychosocial stressor is a major limitation in the existing research. 
This is further exacerbated by the fact that even within one domain, researchers often assume 
that each stressor matters the same amount and timing is often not considered. Most studies focus 
on either childhood-specific events only,14,20 very recent events,38 or events at any point with no 
consideration given to the timing of those events.174,175 These are unlikely to be valid 
assumptions due to both the nature of stressors and the context in which a stressor occurs. 
Additional factors that may affect psychosocial stressors’ impact include intensity of the specific 
stressor, period of the lifecourse in which the stressor occurs, duration of the stressor, and 
quantity of stressors.  
Both Chapters 4 and 5 discuss findings providing evidence that the identified 
relationships with cognitive trajectories are stronger among those with lower educational 
attainment, a proxy for cognitive reserve. These results suggest that cognitive reserve may be an 
important modifier of these relationships and that researchers should strive to include effect 
measure modification analyses by this measure in their studies. However, cognitive reserve is 
still a theoretical concept that we do not know how to accurately measure. Educational 
attainment is often used as a proxy for reserve, as it is in this dissertation, but it is a very rough 
proxy that allows for a large amount of measurement error. Depending on whether the 
“hardware” or “software” hypothesis is correct, data such as fMRI and CT scans may be able to 
help us discover more about this potential construct and its mechanisms of impact. This type of 
data will be essential in moving the cognitive reserve hypotheses forward and incorporating it 
into models for testing in observational studies.  
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Finally, the availability of novel and detailed innate and adaptive peripheral immune 
system biomarkers in longitudinal cohort studies is essential to the further investigation of these 
markers as mediators of the pathway of interest in this dissertation. The Health & Retirement Study 
conducted a supplemental Venous Blood Study in 2016, which includes data on traditional 
immune biomarkers such as cytokines and monocyte and lymphocyte percentages but also 
includes T-cell phenotypes. When the T-cell phenotype data becomes publicly available, it will be 
incredibly useful to understanding immunosenescence in the U.S. Data of this caliber should be 
incorporated in to existing and future observational studies so that research may pursue 
understanding of these cellular pathways at the population level.  
6.5 Conclusions 
 Our novel findings suggest that certain traumatic events may impact cognitive function 
and rate of cognitive decline in late life, although the results are less suggestive for incidence of 
dementia. Results from this study also suggest that the timing of these events within the 
lifecourse is important to the long-term effects they have, and these relationships are modified by 
the educational attainment, potentially cognitive reserve, of the individual. Furthermore, elevated 
immune biomarkers may be indicative of lower cognitive function or accelerating decline in 
older populations, though this relationship, too, was modified by educational attainment and 
cognitive reserve. Cortisol may interact with immune cells to alter the associations with these 
outcomes. While we hypothesize that accelerated immune system aging is a mediator on the 
pathway from psychosocial stressors to cognitive function and incidence of ADRDs, we were 
unable to test this hypothesis in this study. 
This is the first study to investigate how the timing of traumatic events across the 
lifecourse is associated with cognitive decline and dementia, as well as the first to investigate the 
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association of multiple biomarkers of inflammation and infection interact with cortisol and are 
associated with these outcomes. Furthermore, this is the first study to investigate how cognitive 
reserve, proxied by educational attainment, may modify these relationships. This work filled a 
significant gap in the literature regarding the timing of psychosocial stressors and individual 
events versus accumulation of events. It is particularly useful in identifying why there is such 
inconsistency within the existing literature about whether there are associations and in what 
direction they are. Future research will need to connect the exposure of psychosocial stressors to 
the immune markers implicated in cognitive decline and ADRDs. Whether this is a significant 
mediating pathway remains to be seen but warrants further investigation. Investigation of the 
cognitive reserve hypothesis warrants further investigation as well, both in how to best measure 
this construct and how it is associated with cognitive aging outcomes. The public health 
implications of this work are wide ranging. Factors that may affect cognitive aging likely include 
psychosocial stressors, and the time period during which we are vulnerable to these exposures is 
throughout the life course. Cognitive decline and ADRDs are important health outcomes to delay 
and prevent, given their prevalence within the current population and the likelihood of their 
growth. However, much of the population that will develop ADRDs over the next 50 years has 
already experienced traumas, so identifying biological intermediaries, such as immune system 
markers of aging, is also critical to potentially improving outcomes. 
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Figure A1.1. Sample flow chart for cognitive decline analyses showing how the study sample was derived. 































HRS participants completing the Psychosocial & 
Lifestyle Questionnaire in 2006 or 2008 
N = 15,136 
Total participants with exposure data 
N = 14,260 
Total participants without exposure data  
N = 876 
Total participants with at least 2 
cognitive data points 
N = 10,217 
Total participants without at least two 
cognitive data points 
N = 4,043 
Total participants over 65 years old at 
baseline  
N = 7,989 
Total participants not 65 years old at 
baseline  
N = 2,228 
Total participants with complete 
covariate data 
N = 7,785 
Final Sample Size  
Total participants with missing covariate 
data  
N = 204 
 
   129 
Figure A1.2. Sample flow chart for incident dementia analyses showing how the study sample was derived. 


























HRS participants completing the Psychosocial & 
Lifestyle Questionnaire in 2006 or 2008 
N = 15,136 
Total participants with exposure data 
N = 14,260 
Total participants without exposure data  
N = 876 
Total participants with dementia variable 
N = 5,682 
Total participants without dementia 
variable 
N = 8,578 
Total participants over 65 years old at 
baseline  
N = 5,367 
Total participants not 65 years old at 
baseline  
N = 0 
Total participants with complete 
covariate data 
N = 4,780 
Final Sample Size  
Total participants with missing covariate 
data  
N = 587 
Total participants without baseline 
dementia  
N = 5,367 
Total participants with baseline 
dementia 
N = 315 
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Table A1.1. Baseline Sociodemographic and Cognitive Characteristics, by Educational Attainment, of Eligible Health & Retirement 
Study Participants, n = 7,785 
 Overall 




Some College  
(n = 1,584) 
College +  
(n = 1,501) 
 N % N % N % N % N % 
Age, Mean (range) 74 (65, 104) 75 (65, 104) 74 (65, 97) 74 (65, 95) 74 (65, 99) 
           
Sex (N, % Female) 4578 (58.8) 1029 (60.5) 1909 (63.7) 970 (61.2) 670 (44.6) 
Education           
< High School 1702 (21.9)         
High School Diploma 2998 (38.5)         
Some College 1584 (20.4)         
College + 1501 (19.3)         
Race/Ethnicity           
Non-Hispanic White 6182 (79.4) 974 (57.2) 2527 (84.3) 1330 (84.0) 1351 (90.0) 
Non-Hispanic Black 948 (12.2) 382 (22.4) 308 (10.3) 165 (10.4) 93 (6.2) 
Hispanic 535 (6.9) 311 (18.3) 131 (4.4) 68 (4.3) 25 (1.7) 
Other 120 (1.5) 35 (2.1) 32 (1.1) 21 (1.3) 32 (2.1) 
           
TICS Score, Mean (SD) 22 (4.6) 19 (4.8) 22 (3.9) 23 (4.1) 25 (3.8) 
Lifetime Traumatic Events           
0 Events 1740 (22.4) 365 (21.5) 706 (23.6) 320 (20.2) 349 (23.3) 
1 Event 2244 (28.8) 501 (29.4) 887 (29.6) 403 (25.4) 453 (30.2) 
2 Events 1847 (23.7) 423 (24.9) 689 (23.0) 385 (24.3) 350 (23.3) 
3+ Events 1954 (25.1) 413 (24.3) 716 (23.9) 476 (30.1) 349 (23.3) 
Lfetime Traumatic Events (N, % 1 or more)         
Early Life 1478 (19.0) 285 (16.8) 556 (18.6) 340 (21.5) 297 (19.8) 
Young Adulthood 1397 (17.9) 289 (17.0) 478 (15.9) 335 (21.2) 295 (19.7) 
Mid Life 3008 (38.6) 608 (35.7) 1157 (38.6) 675 (42.6) 568 (37.8) 
Late Life 2845 (36.5) 683 (40.1) 1096 (36.6) 581 (36.7) 485 (32.3) 
           
Comorbidities, Mean (SD) 2.2 (1.35) 2.4 (1.47) 2.2 (1.31) 2.2 (1.30) 2.0 (1.30) 
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Table A1.2. Sociodemographic and Cognitive Characteristics, by Educational Attainment, of Eligible HRS Participants, n = 4,780 
 Overall 








 N % N % N % N % N % 
Age, Mean (SD) 77 (67, 99) 78 (67, 96) 77 (67, 97) 78 (67, 95) 77 (67, 99) 
           
Sex (N, % Female) 2838 (59.4) 601 (59.0) 1206 (64.8) 606 (63.2) 425 (45.1) 
Education           
< High School 1018 (21.3)         
High School Diploma 1861 (38.9)         
Some College 959 (20.1)         
College + 942 (19.7)         
Race/Ethnicity           
Non-Hispanic White 3979 (83.2) 632 (62.1) 1624 (87.3) 840 (87.6) 883 (93.7) 
Non-Hispanic Black 518 (10.8) 214 (21.0) 163 (8.8) 90 (9.4) 51 (5.4) 
Hispanic 283 (5.9) 172 (16.9) 74 (4.0) 29 (3.0) 8 (0.9) 
*No Other           
TICS Score, Mean (SD) 22 (4.3) 19 (4.5) 22 (3.7) 23 (3.9) 24 (3.7) 
Lifetime Traumatic Events           
0 Events 999 (20.9) 208 (20.4) 408 (21.9) 183 (19.1) 200 (21.2) 
1 Event 1411 (29.5) 307 (30.2) 562 (30.2) 252 (26.3) 290 (30.8) 
2 Events 1182 (24.7) 267 (26.2) 450 (24.2) 239 (24.9) 226 (24.0) 
3+ Events 1188 (24.9) 236 (23.2) 441 (23.7) 285 (29.7) 226 (24.0) 
Lifetime Traumatic Events (N, % 1 or more)         
Early Life 811 (17.0) 140 (13.8) 318 (17.1) 179 (18.7) 174 (18.5) 
Young Adulthood 871 (18.2) 166 (16.3) 312 (16.8) 200 (20.9) 193 (20.5) 
Mid Life 1582 (33.1) 300 (29.5) 615 (33.1) 352 (36.7) 315 (33.4) 
Late Life 2183 (45.7) 508 (49.9) 839 (45.1) 452 (47.1) 384 (40.8) 
           
Incident Dementia  1416 (29.6) 425 (41.8) 521 (28.0) 272 (28.4) 198 (21.0) 
           
Comorbidities, Mean (SD) 2.2 (1.3) 2.4 (1.4) 2.2 (1.3) 2.2 (1.3) 2.1 (1.3) 
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APPENDIX 2: CHAPTER 5 SUPPLEMENTAL MATERIAL 
 
 
Table A2.1. Fixed Effects Estimates from Linear Mixed Effects Models of Dichotomous Cytokines and Cognitive Decline 
in the SALSA, n=1,337 
   Crude Models  IP Weighted Models  Cortisol Interaction Models 
 Variable  
Estimat
e 95% CI  Estimate 95% CI  Estimate 95% CI 
Interleukin 
- 6 
Intercept  1.9740 ( 1.941, 2.007 )  2.0076 ( 1.973, 2.042 )  2.1481 ( 1.925, 2.372 ) 
IL-6 1 0.1651 ( 0.116, 0.215 )  0.1210 ( 0.070, 0.172 )  -0.6759 -( 0.993, -0.359 ) 
IL6 0 ref . .  ref . .  ref . . 
Age  0.0124 ( 0.003, 0.022 )  0.0145 ( 0.004, 0.025 )  -0.0563 -( 0.123, 0.011 ) 
Agesq  0.0021 ( 0.002, 0.003 )         
Age*Il-6 1 0.0010 -( 0.013, 0.015 )  0.0107 -( 0.004, 0.025 )  0.0518 -( 0.042, 0.146 ) 
Age*Il-6 0 ref . .  ref . .  ref . . 
Cortisol          -0.0554 -( 0.142, 0.031 ) 
Cortisol*IL-6          0.3135 ( 0.191, 0.436 ) 
Cortisol*IL-6          ref . . 
Age*Cortisol*IL-
6 1         0.0108 -( 0.014, 0.036 ) 
Age*Cortisol*IL-
6 0         0.0278 ( 0.002, 0.054 ) 
 
             





Intercept  2.0085 ( 1.975, 2.042 )  2.0524 ( 2.019, 2.086 )  1.7776 ( 1.583, 1.972 ) 
TNF-alpha 1 0.0967 ( 0.045, 0.148 )  0.0355 -( 0.018, 0.089 )  0.2363 -( 0.119, 0.592 ) 
TNF-alpha 0 ref . .  ref . .  ref . . 
Age  0.0132 ( 0.003, 0.023 )  0.0172 ( 0.007, 0.027 )  -0.0237 -( 0.081, 0.033 ) 
Agesq  0.0022 ( 0.002, 0.003 )         
Age*TNF-alpha 1 0.0004 -( 0.014, 0.014 )  0.0076 -( 0.007, 0.022 )  -0.0547 -( 0.158, 0.048 ) 
Age*TNF-alpha 0 ref . .  ref . .  ref . . 
Cortisol          0.1084 ( 0.033, 0.184 ) 
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Cortisol*TNF-
alpha          -0.0804 -( 0.217, 0.057 ) 
Cortisol*TNF-
alpha          ref . . 
Age*Corisol*TN
F-alpha 1         0.0396 ( 0.007, 0.072 ) 
Age*Corisol*TN
F-alpha 0         0.0159 -( 0.006, 0.038 ) 
 
             
              
C-reactive 
Protein 
Intercept  1.9995 ( 1.965, 2.034 )  2.0370 ( 2.001, 2.073 )  1.9147 ( 1.688, 2.142 ) 
CRP 1 0.0983 ( 0.049, 0.148 )  0.0473 -( 0.004, 0.098 )  -0.2284 -( 0.553, 0.096 ) 
CRP 0 ref . .  ref . .  ref . . 
Age  0.0178 ( 0.008, 0.028 )  0.0233 ( 0.013, 0.033 )  -0.0500 -( 0.115, 0.015 ) 
Agesq  0.0021 ( 0.001, 0.003 )         
Age*CRP 1 -0.0066 -( 0.020, 0.007 )  -0.0039 -( 0.018, 0.011 )  0.0097 -( 0.085, 0.105 ) 
Age*CRP 0 ref . .  ref . .  ref . . 
Cortisol          0.0478 -( 0.041, 0.136 ) 
Cortisol*CRP          0.1066 -( 0.019, 0.232 ) 
Cortisol*CRP          ref . . 
Age*Cortisol*CR
P          0.0226 -( 0.004, 0.049 ) 
Age*Cortisol*CR
P                   0.0287 ( 0.003, 0.054 ) 
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Table A2.2. Fixed Effects Estimates from Linear Mixed Effects Models of Pathogen Seropositivity and Cognitive Decline in the SALSA, 
n=1,093 
   Crude Models  IP Weighted Models  Cortisol Interaction Models 
 Variable  Estimate 95% CI  
Estimat
e 95% CI  Estimate 95% CI 
HSV-1 
Intercept  2.0162 ( 1.943, 2.090 )  2.0662 ( 1.990, 2.142 )  1.7016 ( 1.162, 2.241 ) 
HSV-1 1 -0.0047 -( 0.083, 0.074 )  -0.0314 -( 0.113, 0.050 )  0.0949 -( 0.474, 0.664 ) 
HSV-1 0 ref . .  ref . .  0.0000 . . 
Age  0.0099 -( 0.011, 0.031 )  0.0190 -( 0.002, 0.041 )  -0.1007 -( 0.262, 0.061 ) 
Age2  0.0025 ( 0.002, 0.003 )         
Age*HSV-1 1 0.0049 -( 0.017, 0.027 )  0.0037 -( 0.019, 0.027 )  0.0703 -( 0.100, 0.241 ) 
Age*HSV-1 0 ref . .  ref . .  0.0000 . . 
Cortisol          0.1416 -( 0.067, 0.350 ) 
Cortisol*HSV-1          -0.0488 -( 0.269, 0.171 ) 
Cortisol*HSV-1          0.0000 . . 
Age*Cortisol*HSV-1 1         0.0205 -( 0.001, 0.042 ) 
Age*Cortisol*HSV-1 0         0.0453 -( 0.016, 0.107 ) 
 
             
 
             
CMV 
Intercept  1.8069 ( 1.745, 1.869 )  1.8793 ( 1.814, 1.945 )  1.3580 ( 0.935, 1.781 ) 
CMV 1 0.2508 ( 0.183, 0.319 )  0.1853 ( 0.113, 0.257 )  0.4555 -( 0.007, 0.918 ) 
CMV 0 ref . .  ref . .  ref . . 
Age  -0.0010 -( 0.020, 0.018 )  0.0042 -( 0.016, 0.025 )  0.0592 -( 0.067, 0.185 ) 
Age2  0.0025 ( 0.002, 0.003 )         
Age*CMV 1 0.0163 -( 0.005, 0.037 )  0.0202 -( 0.002, 0.042 )  -0.1198 -( 0.258, 0.018 ) 
Age*CMV 0 ref . .  ref . .  0.0000 . . 
Cortisol          0.1991 ( 0.040, 0.359 ) 
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Cortisol*CMV          -0.1013 -( 0.277, 0.074 ) 
Cortisol*CMV          0.0000 . . 
Age*Cortisol*CMV 1         0.0327 ( 0.011, 0.054 ) 
Age*Cortisol*CMV 0         -0.0219 -( 0.070, 0.026 ) 
 
             
 
             
VZV  
Intercept  2.0308 ( 1.999, 2.063 )  2.0415 ( 2.009, 2.074 )  1.7147 ( 1.512, 1.918 ) 
VZV 1 -0.0670 -( 0.126, -0.008 )  -0.0014 -( 0.062, 0.060 )  0.3682 -( 0.026, 0.762 ) 
VZV 0 ref . .  ref . .  ref . . 
Age  0.0133 ( 0.004, 0.023 )  0.0194 ( 0.010, 0.029 )  -0.0428 -( 0.105, 0.019 ) 
Age2  0.0025 ( 0.002, 0.003 )         
Age*VZV 1 0.0040 -( 0.012, 0.020 )  0.0073 -( 0.010, 0.025 )  0.0081 -( 0.111, 0.127 ) 
Age*VZV 0 ref . .  ref . .  0.0000 . . 
Cortisol          0.1268 ( 0.049, 0.205 ) 
Cortisol*VZV          -0.1453 -( 0.299, 0.009 ) 
Cortisol*VZV          0.0000 . . 
Age*Cortisol*VZV 1         0.0240 -( 0.015, 0.063 ) 
Age*Cortisol*VZV 0         0.0237 ( 0.000, 0.047 ) 
 
             
 




Intercept  1.6898 ( 1.601, 1.779 )  1.7943 ( 1.701, 1.887 )  1.2220 ( 0.474, 1.970 ) 
H. pylori 1 0.3530 ( 0.260, 0.446 )  0.2711 ( 0.174, 0.368 )  0.5881 -( 0.180, 1.356 ) 
H. pylori 0 ref . .  ref . .  ref . . 
Age  0.0157 -( 0.009, 0.041 )  0.0238 -( 0.002, 0.050 )  -0.0878 -( 0.315, 0.139 ) 
Age2  0.0025 ( 0.002, 0.003 )         
Age*H. pylori 1 -0.0024 -( 0.028, 0.024 )  -0.0024 -( 0.029, 0.025 )  0.0540 -( 0.179, 0.287 ) 
Age*H. pylori 0 ref . .  ref . .  0.0000 . . 
Cortisol          0.2191 -( 0.066, 0.505 ) 
Cortisol*H. pylori          -0.1196 -( 0.413, 0.174 ) 
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Cortisol*H. pylori          0.0000 . . 
Age*Cortisol*H. 
pylori 1         0.0211 ( 0.001, 0.042 ) 
Age*Cortisol*H. 
pylori 0         0.0422 -( 0.043, 0.128 ) 
 
             
 




Intercept  1.9984 ( 1.966, 2.031 )  2.0582 ( 2.025, 2.092 )  1.7541 ( 1.547, 1.961 ) 
T. gondii 1 0.0404 -( 0.015, 0.096 )  -0.0591 -( 0.117, -0.001 )  0.1736 -( 0.205, 0.552 ) 
T. gondii 0 ref . .  ref . .  ref . . 
Age  0.0159 ( 0.006, 0.026 )  0.0230 ( 0.013, 0.033 )  -0.0246 -( 0.086, 0.037 ) 
Age2  0.0025 ( 0.002, 0.003 )         
Age*T. gondii 1 -0.0056 -( 0.022, 0.010 )  -0.0032 -( 0.020, 0.014 )  -0.0554 -( 0.174, 0.063 ) 
Age*T. gondii 0 ref . .  ref . .  0.0000 . . 
Cortisol          0.1183 ( 0.039, 0.198 ) 
Cortisol*T.gondii          -0.0919 -( 0.239, 0.055 ) 
Cortisol*T.gondii          0.0000 . . 
Age*Cortisol*T.gond
ii 1         0.0388 ( 0.000, 0.078 ) 
Age*Cortisol*T.gond
ii 0         0.0181 -( 0.005, 0.042 ) 
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